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ABSTRACT  
 Shortfalls in quality of care and rising costs have resulted in a widespread 
interest in developing strategies that enhance the efficiency of health care 
delivery. The implementation of multidisciplinary integrative teams of providers is 
a popular quality improvement intervention designed to manage patients with 
chronic conditions. However, little attention has been paid to the work 
environment, which may facilitate organizational change success. Relational 
climate is a measure of the work environment that captures shared employee 
perceptions of interpersonal relationships including teamwork, conflict resolution 
and diversity acceptance. A strong relational climate may improve treatment 
design, care delivery and process evaluation, leading to better quality and lower 
costs. 
 This dissertation contains three chapters that seek to understand the 
influence of relational climate in primary care on quality and costs of diabetes 
care. Study 1, Relational Climate and Quality of Diabetes Care, measured quality 
of diabetes care using process-based and intermediate outcome indicators. It 
assessed whether relational climate was associated with quality of diabetes care. 
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We used longitudinal data (2008– 2012) from the Veterans Health 
Administration. Multivariate regression analyses accounting for patient, clinic and 
parent facility characteristics suggested a positive association between relational 
climate and process-based indicators of diabetes quality of care.  
 Study 2, Relational Climate and Costs of Diabetes Care, evaluated the 
association between relational climate and costs incurred by diabetic patients 
differentiating among outpatient, inpatient and total costs. It compared a 
Generalized Linear Model with the gamma distribution and the log link and a 
logged model with the Duan’s smearing adjustor. Cost models accounted for 
quality of diabetes care, besides other patient and clinic characteristics. Results 
indicated that relational climate contributes to lower outpatient and total costs. 
 Study 3, The Indirect Association of Relational Climate and Costs through 
Quality, refines the cost-saving estimates of relational climate by accounting for 
the indirect influence of relational climate on costs through quality. The quality 
and the cost equations were estimated simultaneously within a treatment-effects 
model to account for selection bias in treatment compliance. We concluded that a 
stronger relational climate contributes to lower total costs. 
 The results of this dissertation suggest that improving relational climate is 
a cost-effective intervention.  
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CHAPTER 1: INTRODUCTION 
 Diabetes is a highly prevalent, complex to manage, and costly public health 
problem. Diabetic patients are at risk of developing complications and multiple 
comorbidities. Effective provision of diabetes care often requires the distribution of tasks 
across a multidisciplinary team to deliver continuous, coordinated and timely care. 
Relational climate is a measure of the work environment. It captures shared perceptions 
of teamwork, conflict resolution and diversity acceptance. Relational climate may 
enhance the provision of diabetes care by optimizing the use of the skill sets of 
employees within primary care teams. A stronger relational climate may foster attitudes 
and behaviors such as high effort levels, work-group cohesion and coordination. This 
dissertation examines the association among relational climate, diabetes quality and 
cost of care at the Veterans Health Administration (VHA) between 2008 and 2012. 
The prevalence of diabetes among the general U.S. population, and particularly 
at the VA, is alarming (8% and 22% respectively) (Congressional Budget Office, 2009). 
Unmanaged diabetes can lead to serious complications, which pose a high social 
burden and are the main driver of diabetes health care costs (American Diabetes 
Association, 2005). Total outpatient costs of diabetic patients at the VHA accumulated to 
$6 billion and total inpatient costs to $4 billion in 2008 (Department of Veterans Affairs, 
2014).  
This chapter will present the conceptual basis of this research. It includes a 
revision of the relevant literature on organizational climate, relational climate, quality of 
diabetes care and costs, along with a description of the conceptual framework. The 
subsequent three chapters are separate studies aimed at evaluating the observed 
relationships between relational climate and patient outcomes. The first study, Relational 
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Climate and Quality of Diabetes Care, describes the association between relational 
climate and diabetes quality of care. Quality is measured through both process-based 
and intermediate outcome indicators. The second study, Relational Climate and Costs of 
Diabetes Care, evaluates the association between relational climate and health care 
costs differentiating among outpatient, inpatient and total costs. Finally, the third study, 
The Indirect Association of Relational Climate and Costs through Quality, builds on the 
prior two studies to compute the indirect observed influence of relational climate on costs 
through quality. It presents a final estimation of the total cost-saving potential of 
relational climate. 
 
Organizational climate 
Organizational climate is a multidimensional measure of the individual-
organizational relationship (Glick, 1985). It reflects shared understanding of the 
behaviors that are expected, rewarded and supported at the organization (Ostroff, C., 
Kinicki, A. J., & Tamkins, M., 2003). Organizational climate originates from psychological 
climate, but they are two distinct constructs (L. A. James & James, 1989; L. R. James et 
al., 2008; James, L.R., & Jones, A.P., 1974). Psychological climate refers to the 
individual perceptions and meaning attached to the policies, procedures, and practices 
of an organization. Policies define strategic goals and means of goal attainment, 
whereas procedures provide practical guidelines for action related to these goals and 
means. Practices, on the other hand, relate to the implementation of policies and 
procedures in each subunit (Zohar, 2000). For instance, an organization may implement 
policies supporting diversity, procedures to deal with conflict, and practices to encourage 
cooperation and knowledge sharing. All these dimensions influence interpersonal 
	3	
relationships and teamwork. Organizational climate emerges when certain perceptions 
are shared by the members of a unit or organization. Therefore, organizational climate is 
considered within the literature as a collective, summary description of the work 
environment, measured at the individual level but analyzed at a higher level (L. A. James 
& James, 1989; Rousseau, D. M., 1988).  
The relationship between organizational climate and patient outcomes has been 
underexplored and existing evidence is mixed. Aiken and colleagues found that the 
organizational climate of nurses positively influenced quality of hospital care based on 
300 hospitals from the U.S., Canada and the U.K. (Aiken, Clarke, & Sloane, 2002). 
Estabrooks and colleagues reported no significant association between organizational 
climate and 30-day mortality based on 49 acute care hospitals in Canada (Estabrooks, 
Midodzi, Cummings, Ricker, & Giovannetti, 2005). Further research should explore how 
organizational climate relates to disease specific process measures and intermediate 
outcomes of care. Also, focusing on specific dimensions of the work environment (e.g. 
safety climate (Singer, Lin, Falwell, Gaba, & Baker, 2009)) could be informative to the 
design of quality improvement interventions.  
 
Organizational climate and teamwork 
Diabetic patients have high comorbidity, averaging having five different medical 
problems (Beasley et al., 2004). The complexity of this chronic disease often requires a 
multidisciplinary care team including primary care providers, nurses, specialists and 
pharmacists, among others. Existing research suggests that diabetes management can 
be improved through collaboration and teamwork (Maislos & Weisman, 2004; The 
California Medi-Cal Type 2 Diabetes Study Group, 2004).  
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Xyrichis and Ream define teamwork in healthcare as a dynamic process 
involving more than one health care professional with complementary backgrounds and 
skills, sharing common goals, and devoting physical and mental effort in evaluating and 
providing patient care (Xyrichis & Ream, 2008). Effective teamwork often relies on 
practices that guide and standardize tasks. Some examples include procedures to triage 
patient phone calls, to discuss diagnosis and treatment options, and to communicate 
them to patients (Broek, Callaghan, & Thompson, 2004; McCallin, 2001). Existing 
literature suggests that effective teamwork might improve job satisfaction (Rafferty, Ball, 
& Aiken, 2001), reduce turnover rates (Borrill, Carol S.; Carletta, J.; Dawson, Jeremy; 
Garrod, S.; Rees, Anne; Richards, 2001) and lower hospitalization rates (Baggs et al., 
1999; Ball, Kirkby, & Williams, 2003; Sommers LS, Marton KI, Barbaccia JC, & 
Randolph J, 2000). Also, teamwork might reduce costs (Curley, McEachern, & Speroff, 
1998; Mickan, 2005). Rogelberg and colleagues found that group decisions surpassed 
the quality of individual decisions 56% of the time (Rogelberg, Barnes-Farrell, & Lowe, 
1992).Teams seem to make fewer mistakes than individuals, especially when 
responsibilities are well defined across the team members (Baker, Day, & Salas, 2006).  
Notice that teamwork is not an inherent characteristic of teams. Members of the 
same formal team structure may be unable to interact successfully with each other due 
to lack of shared goals, motivation and teamwork skills. Organizational climate may 
explain the use and efficiency of teamwork. Organizational policies, procedures and 
practices signal to employees the norms and expectations that characterize the goals 
and functioning of the organization. Efficient teamwork arises in pro-teamwork work 
environments that convey norms and expectations regarding the benefits of teamwork, 
collaboration and communication through policies, procedures and practices such as 
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team-based reward systems, educational resources and open communication spaces 
(Aliereza Mooghali, 2012; Salas & Frush, 2012). Employees may be more motivated in 
pro-teamwork work environments and, as a result, exert higher effort levels (Noordin, 
Omar, Sehan, & Idrus, 2010). Therefore, a strong organizational climate may improve 
teamwork efficiency by influencing employee motivation, effort and commitment. 
 
Relational climate 
Relational climate captures shared perceptions of policies, procedures, and 
practices related to interpersonal relationships (Mossholder, Richardson, & Settoon, 
2011). It includes perceptions of policies supporting diversity, procedures to deal with 
conflict, and practices to encourage cooperation and teamwork (J. K. Benzer et al., 
2011). Relational climate is a molar climate (J. K. Benzer et al., 2011; Mossholder et al., 
2011). Molar or foundational climates characterize shared perceptions for the basic 
characteristics of the work environment, in contrast to facet-specific climates that are 
focused on particular outcomes such as safety climate (Singer et al., 2009; Wallace, 
Popp, & Mondore, 2006). Our interest is on a molar climate because it provides a 
broader manifestation of the work environment that may be more relevant to the inherent 
multidimensionality of diabetes quality of care (O’Connor et al., 2011; R. R. Rubin & 
Peyrot, 1999).  
Relational climate emphasizes the value of relationship-oriented strategies, 
which should promote trust and supportive collaborations among staff, leading to 
improved communication and coordination among health professionals. Consequently, 
health outcomes might improve. Benzer and colleagues found that relational climate 
contributed to process-based quality indicators for diabetes care using 2007 VA data. 
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Relational climate was related to a higher probability of undergoing foot examinations 
and HbA1c tests. (J. K. Benzer et al., 2011). In another study, a strong association was 
found between relational climate, job performance and turnover rates (J. Benzer & 
Horner, 2015). However, these results are based on cross-sectional study designs. 
Unobserved or unmeasured variables in the error term associated with relational climate 
and quality (e.g. leadership style or communication among providers) may bias the 
results. This dissertation further observed associations between the work environment 
and quality and costs of diabetes care using panel data, which minimizes the impact of 
the presence of unmeasured or unobserved variables. Also, quality of diabetes care will 
be measured with alternative process-based indicators. To our knowledge, the 
association between relational climate and costs remains unexplored. 
 
Measurement of relational climate 
We measured relational climate using three questions asked on the VHA All 
Employees Survey (AES). The AES is administered annually and measures employees’ 
perceptions and levels of satisfaction with their work environments. The three Likert-type 
items capture employee perceptions on teamwork and cooperation, conflict resolution, 
and diversity acceptance. This relational climate scale has shown adequate internal 
consistency in prior work (Cronbach’s alpha ≥0.86)(J. K. Benzer et al., 2011).The 
response choices range from “strongly disagree” to “strongly agree”. Notice that 
relational climate captures the shared perceptions of these constructs, which, unlike 
specific behaviors, are psychological states. The first component of relational climate 
involves employee perceptions of cooperation and teamwork and specifically asks “A 
spirit of teamwork and cooperation exists in my group”. 
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The second component of relational climate relates to employee perceptions of 
conflict resolution. The AES question is “Disputes or conflicts are resolved fairly in my 
workgroup”. Group conflict emerges when there are real or perceived differences among 
the members of a group (De Dreu & Weingart, 2003; de Wit, Greer, & Jehn, 2012). 
Conflict may steam from relationships, tasks or processes. Relationship-based conflict 
originates from differences in personality, norms or values; while task conflict involves 
disagreement in decisions, viewpoints and ideas about a given task. Finally, process-
based conflict deals with the logistics of task accomplishment such as task delegation 
(Bradley, Postlethwaite, Klotz, Hamdani, & Brown, 2012).  
Existing literature concurs that relationship-based conflict has a negative impact 
on group performance.  Resentment may arise, time may be inefficiently spent 
discussing non-task-related issues and group members may be less willing to 
collaborate. Task conflict also may have a negative effect on performance, but it may 
also encourage creativity and better decision making by challenging current practices. 
Process-based conflict seems to have a predominantly negative impact on group 
outcomes (Bradley et al., 2012; de Wit et al., 2012). 
The existence of strong conflict resolution procedures is often a requirement to 
achieve effective teamwork functioning. In interdisciplinary practices not all members 
have similar attitudes towards tasks or organizational goals and take equitable 
responsibilities. These value differences are potential sources of conflict. Conflict 
resolution procedures (such as early detection of disagreement, establishing common 
goals and identifying barriers to them)  may facilitate team maturation and cohesion (Hall 
& Weaver, 2001).  
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The third component of relational climate deals with employee perceptions of 
procedures on diversity acceptance and it is phrased on the AES as “Differences among 
individuals are respected and valued in my work group”. At the organizational level 
diversity acceptance captures the degree to which a firm implements fair employee 
policies and socially integrates underrepresented employees (based on either 
demographic or personality traits) into the work setting (McKay, Avery, & Morris, 2009; 
Mor Barak, 2009). Equity theory postulates that employees consider being treated fairly 
if the ratio of input (contribution to the relational exchange) to output (consequences) is 
similar to those around them (Stacy, 1963). Existing research has shown that perceived 
equity may predict job performance (Bing & Burroughs, 2001) and intention to leave 
(O’Neill & Mone, 1998).  
Existing evidence assessing the impact of diversity on organizational 
performance is mixed. Diversity has the potential of improving creativity and decision-
making as heterogeneous groups are more likely to possess a broader range of relevant 
knowledge than homogeneous groups (Gilbert & Ivancevich, 2000). On the other hand, 
diversity may increase organizational conflict and reduce trust, leading to higher turnover 
rates and job dissatisfaction (Jehn, Northcraft, & Neale, 1999). The positive effects of 
diversity are facilitated by inclusive group behaviors such as openness to diversity, equal 
group status and cooperation (Hobman, Bordia, & Gallois, 2004). Hobman and 
colleagues found that when group openness was low, perceived dissimilarity had a 
negative impact on work group involvement. The authors highlight the importance of 
managing perceptions of difference with an active involvement of all team members to 
optimize performance. Policies aimed at fostering diversity acceptance are necessary to 
minimize conflict and consolidate diversity as an organizational asset (Ely, 2004).  
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Quality of diabetes care   
Quality of care is an inherently multidimensional construct defined by technical 
and interpersonal components (Arah, Roset, Delnoij, Klazinga, & Stronks, 2013; Arah, 
Westert, Hurst, & Klazinga, 2006). Technical quality includes structures, processes and 
outcomes of care. Structures describe the context where care is delivered, including 
organizational characteristics such as human resources and equipment. Processes 
capture both patient and provider actions related to actual treatment. They encompass 
seeking care, diagnosis of medical conditions, treatment prescription and adherence. 
Finally, outcomes of care describe the effects of medical care on patient health status, 
knowledge or satisfaction (Donabedian, 1988). On the other hand, interpersonal quality 
of care is concerned with patient centeredness measured through patient satisfaction 
and, more broadly, patient care experiences (Arah et al., 2006).   
The quality indicators employed in this dissertation are aimed at capturing 
technical quality, including both processes and intermediate outcomes of diabetes care. 
Processes-based quality indicators describe whether the tests and procedures 
recommended by the American Diabetes Association (ADA) were performed, including 
hemoglobin A1C (HbA1c), low-density lipoprotein cholesterol (LDL-C), blood pressure, 
nephropathy and foot examination. Intermediate outcomes refer to the actual results of 
these tests. System and patient characteristics will be conceptualized as determinants of 
quality of care.  
The Institute of Medicine has emphasized the importance of measuring quality 
considering its inherent multidimensionality and in a longitudinal fashion (D. R. Miller & 
Pogach, 2008). Studies at the VHA mostly measured quality of diabetes care with a 
single indicator, often HbA1c (Jackson et al., 2005; Safford, 2009; Q. Zhang et al., 
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2000). Jackson and colleagues examined organizational characteristics in primary care 
associated with better HbA1c levels in 2005. Higher staffing autonomy to implement 
clinical practices and the organization of care delivery into multidisciplinary clinical teams 
were positively associated with quality of diabetes care.  
Benzer and colleagues used multiple indicators to measure quality of diabetes 
care. Process-based indicators included whether the patient underwent HbA1c testing 
and foot examinations. Intermediate outcome indicators captured whether HbA1c<9, 
LDL-C<120mg/dL, and blood pressure <140/90. Adjusting for patient and clinic 
covariates, a positive relationship between relational climate and process-based quality 
of diabetes care indicators was found (J. K. Benzer et al., 2011).  
 
Costs of diabetes care 
The relationship between relational climate and costs of diabetes remains 
unexplored. Existing research suggests that teamwork, which is influenced by 
organizational climate, has the potential of improving resource allocation and reducing 
costs (Risser et al., 1999; Wade & Kleiner, 1998; Zwarenstein, Goldman, & Reeves, 
1996). Wade and Kleiner found that teamwork and staff empowerment were shared 
characteristics among the most successful (in terms of both costs and quality) health 
maintenance organizations. Risser and colleagues estimated that better team 
functioning, resulting from improved communication and coordination, reduced medical 
errors and saved nearly $345,460 per 100,000 emergency department visits. 
Zwarenstein concluded based on a literature review that better collaboration between 
nurses and doctors could reduce health care costs. The reported cost savings of a 
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quality improvement intervention based on multidisciplinary rounds and post discharge 
patient follow-up were $978 per patient (Ettner et al., 2006). 
 
Conceptual framework 
In order to understand the complex multilevel factors that promote diabetes 
quality of care and affect costs of diabetic patient, a conceptual framework was 
developed (Figure 1.1). It structures the influence of organizational characteristics on 
health care outcomes based on the Klein & Kozlowski Multilevel Model Linking Human 
Resources (HR) Systems and Firm Performance (K. J. Klein & Kozlowski, 2000). It also 
borrows the role of the community and the chronic care facilitating management 
mechanisms from the Chronic Care Model (E. H. Wagner, 2000), and the predisposing 
and enabling characteristics from the Andersen Model (Andersen, 1995). 
The Klein & Kozlowski Multilevel Model postulates that the management of HR is 
essential to organizational performance. HR refers to the policies, procedures, and 
practices that are designed to yield productive, motivated and satisfied employees that in 
turn are expected to improve organizational performance.  The Klein & Kozlowski model 
outlines the influence of HR across the different layers of the organization, including a 
micro and a macro level premise. There is a cross-level premise linking the micro and 
the macro constructs represented with dashed arrows in Figure 1.1. Both the micro and 
the macro premises are necessary perspectives to explain organizational behavior. 
The micro premise relates HR practices to psychological climate. Psychological 
climate affects employee attributes including attitudes and behaviors, and skills and 
abilities, which in turn influence individual performance and outcomes. Some examples 
of individual attitudes and behaviors are motivation, commitment and satisfaction. For 
example, HR practices such as training, development of teamwork skills and job 
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enrichment may influence motivation and commitment.  
The macro premise postulates that HR practices influence organizational climate. 
Organizational climate determines group attributes (including collective attitudes and 
behaviors), and leverages human capital, the skills and abilities of the workforce that are 
needed to achieve organizational goals (Russell, Todd, Combs, Woehr, & Ketchen Jr., 
2011). Some examples of collective attitudes and behaviors are average job satisfaction 
across the organization, turnover rates and citizenship. Lack of job satisfaction across 
the organization might lead to higher turnover rates and absenteeism, which can be 
costly for the organization (Waldman, Kelly, Arora, & Smith, 2004).  
The disease-specific focus of this dissertation required to complement the 
generic Klein & Kozlowski framework with the Chronic Care Model to fully characterize 
the organizational factors that explain patient outcomes in diabetes care. The Chronic 
Care Model was developed to guide quality improvement for chronic conditions 
(Coleman, Austin, Brach, & Wagner, 2009). It identifies the essential elements of the 
healthcare system that foster quality of care in chronic diseases. The framework 
postulates that functional and clinical outcomes are the result of productive interactions 
between informed patients and prepared practice teams. Both the community and the 
health system influence these synergies. Health care organizations may incorporate 
activities and strategies aimed at facilitating effective chronic illness management, 
including self-management support, delivery system design, decision support, and 
clinical information systems. Self-management support refers to activities that empower 
patients and prepare them to manage their health condition more effectively. Delivery 
system design is aimed at optimizing task assignment by implementing well-coordinated 
multidisciplinary teams. Decision support implies promoting clinical care consistent with 
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scientific evidence and taking into account patients’ preferences. Providers should share 
with their patients the most updated information about treatment choices and engage 
patients in the decision-making process. Finally, clinical information systems are aimed 
at organizing patient and population data to inform effective care. Access to complete 
health information and timely reminders to providers are some examples.  
The influence of patient characteristics on care engagement and health 
outcomes is not accounted for in either the Klein and Kozlowski Multilevel Model or the 
Chronic Care Model.  The Andersen Model structures the patient determinants of health 
care use into predisposing and enabling factors (Andersen, 1995). Some examples of 
predisposing characteristics are demographic traits (e.g. age, gender and race), 
comorbidities and disease severity. Enabling factors comprise social support, access to 
care, and socioeconomic status, among others. 
The proposed conceptual framework (Figure 1.1) also incorporates the 
organizational context. Johns defines context as the situational opportunities and 
constraints that affect the occurrence and meaning of organizational behavior (Johns, 
2006). Johns differentiates between omnibus (context broadly considered) and discrete 
(particular variables that shape behavior) contexts. Omnibus context includes location 
(geographic, social and class composition), time (evolving technology, major 
organizational changes) and occupational and demographic characteristics. Discrete 
context relates to task characteristics (autonomy, uncertainty, resources), social 
interactions (social structure and influence), and physical attributes (temperature, light 
and building structure). Both health care organizations and patients are exposed to and 
interact with the external environment in complex ways. These factors include 
geographic location, public policies, disease prevalence, community engagement, 
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among other factors.  
Notice that Figure 1.1 is a dynamic framework defined by highly intertwined 
components subject to change over time. For example, leaders and managers may 
decide to flatten the organizational structure by implementing HR practices such as 
increased employee autonomy, job enrichment and teamwork use. As a result, 
employee perceptions of the organization (including beliefs and expectations) will vary. 
Over time, new shared beliefs will appear and organizational climate will change. A time 
lag is likely to exist between the adoption of new HR practices and changes in 
organizational climate (Huselid & Becker, 1996) . Therefore, longitudinal analyses are 
essential to capture fully the relationships between organizational behavior and patient 
outcomes.   
Figure 1.1 integrates three previously developed conceptual frameworks to 
describe how relational climate may influence quality and costs of diabetes care. It also 
recognizes the importance of patient characteristics, contextual and environmental 
factors in explaining these outcomes. Figure 1.2 presents in red boxes the constructs 
that we are able to measure and, thus, are the focus of this dissertation. We postulate 
that technical quality and costs of diabetes care are influenced by environmental factors 
(e.g. state-level diabetes prevalence), patient characteristics (Elixhauser comorbidity 
index), organizational contextual factors (e.g. teaching status), collective attitudes and 
behaviors (turnover rate) and, most importantly, relational climate.  We hypothesize that 
relational climate influences quality and costs of diabetes care by fostering pro-teamwork 
behaviors. Efficient diabetes care often relies on well-functioning groups of providers 
including primary care providers, nurses, specialists, pharmacists, among others. 
Providers may feel more motivated and exert higher levels of effort when they perceive a 
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work environment with a strong spirit of cooperation and teamwork, fair resolution of 
conflicts and diversity acceptance (i.e. high relational climate). As a result, diabetes care 
may become more efficient (higher technical quality and lower costs) by improving 
treatment design, execution and evaluation with well-functioning integrated teams of 
providers.  
 This dissertation borrows structural concepts from health outcomes research, 
organizational behavior and economics. Previous research by health outcomes 
researchers has focused on quality measurement, organizational theorists have 
explored organizational climate and teamwork issues, and economists have studied 
costs. The interdisciplinary approach followed in this dissertation puts these three 
perspectives together in a quite innovative way. Developing a deeper understanding of 
the influence of organizational variables on patient outcomes is essential to inform the 
design of interventions aimed at improving quality of diabetes care and controlling costs.   
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Figure 1.1: Conceptual framework 
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Figure 1.2: Conceptual framework, measured constructs 
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CHAPTER 2: RELATIONAL CLIMATE AND QUALITY OF DIABETES CARE 
 
Background 
 Successful diabetes quality improvement strategies often revolve around 
enhancing team functioning. Expanding roles, building multidisciplinary teams based on 
patient needs and collaboratively providing care is a common formula to improve care 
delivery (Kahn & Anderson, 2009; Shojania KG, Ranji SR, McDonald KM, & et al, 2006; 
E. H. Wagner, 2000). Relational climate is an important dimension of the work 
environment that may facilitate collaborative employee behavior (J. K. Benzer et al., 
2011; Mossholder et al., 2011). Relational climate captures shared perceptions of 
interpersonal interactions including teamwork, conflict resolution, and diversity 
acceptance.  
Relational climate may be particularly relevant to diabetes care, which often 
requires interdependent relationships among primary care providers, nurse educators, 
specialists, pharmacists or social workers over an extended time period (Harris & Zwar, 
2007; E. H. Wagner, 2000). This presents unique challenges to the health care system, 
which is generally designed to provide acute care (Conrad & Shortell, 1996, 1996; Ellen 
& Martin, 2008). Only 7% of diabetic patients complied with the ADA guidelines 
(American Diabetes Association 2011) for HbA1c, LDL-C and blood pressure in 2010 
(Bojadzievski & Gabbay, 2011), indicating poor quality of diabetes care. Barriers for 
adherence include disease specific characteristics, patient behavior, and health care 
system issues (Larme & Pugh, 1998; Rätsep, Oja, Kalda, & Lember, 2007).  
The aim of this chapter is to assess whether relational climate is associated with 
diabetes quality of care across time. The innovation of this enquiry resides in the 
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longitudinal study design and in measuring diabetes quality of care using both process-
based and intermediate outcome indicators. Organizational factors such as relational 
climate underlying diabetes management can be subject to change. Further 
understanding of their influence on patient outcomes is needed to achieve primary care 
excellence. 
 
Methods 
Study sample 
The study was conducted at the VHA. It is the largest integrated health system in 
North America. It provides care to more than 8.3 million veterans through more than 
1,400 sites of care including hospitals and community-based outpatient clinics (CBOC) 
among other various facilities. CBOCs facilitate access to care by offering common 
outpatient services without the hassle of visiting a VHA hospital. Both hospital-based 
primary care clinics (HBC) and CBOCs were considered in this analysis. 
The study sample included patients with at least two diabetes diagnoses 
between 2008 and 2012. Diagnosis codes were retrieved from inpatient admissions, 
outpatient encounters, and providers’ problem lists. Diabetes diagnoses were identified 
using ICD-9 codes (250 to 250.93). To assign patients to clinics, we categorized 
outpatient encounters as either primary care or specialty care using provider type and 
the procedures performed during the visit (CPT codes) (Burgess et al., 2011).  Patients 
who visited multiple clinics were assigned to the clinic they visited most often to obtain 
primary care services. Patients without primary care visits in a given year were assigned 
to a clinic based on specialty care visits.  
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Data Sources 
Quality of diabetes care 
Quality of diabetes care was measured through process-based indicators and 
intermediate outcomes. Two process-based indicators were tested. An all-or-none 
process indicator was created to capture whether patients underwent all the tests and 
examinations recommended by the ADA guidelines, including HbA1c, LDL-C, blood 
pressure, retinal, nephropathy and foot examination. All-or-none measures are 
recommended when their components are indisputable basics of care for a given 
condition. These indicators reduce ceiling effects and encourage concern with the 
design of the whole sequence of care rather than its independent parts (Nolan T & 
Berwick DM, 2006). The second process measure was the number of tests and 
procedures conducted. This measure indicates how close individuals are to compliance 
and may help identifying factors contributing to more testing. 
Intermediate outcomes for diabetes quality of care are low HbA1c, LCL-C and 
blood pressure. Typically, these outcomes are evaluated as dichotomous variables with 
specific thresholds (e.g. HbA1c < 9 (National Quality Forum, 2008)). We assessed each 
intermediate outcome as a continuous dependent variable. This approach recognizes 
system improvements towards optimal targets, which is disregarded by thresholds 
(Safford, 2009; Safford et al., 2009). For each year, a single measurement was randomly 
selected.  Computing an average of different measurements within a year for each 
patient could have imposed some degree of regression towards the mean on the 
resulting quality measure. 
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Relational climate 
The VHA AES is conducted annually and measures employees’ perceptions and 
levels of satisfaction with their work environments. AES coordinators at each medical 
center organize employees into workgroups, which share at least one supervisor. 
Respondents are instructed to complete the AES based on their assigned workgroup. 
Response rates decreased from 72.8% in 2008 to 63.4% in 2012, probably at least 
partly related to survey fatigue.  So some degree of concern about result consistency 
over time is warranted. Relational climate is measured with three Likert-type items about 
teamwork and cooperation, conflict resolution, and diversity acceptance (Table A1). 
These three questions form a relational climate scale with adequate internal consistency 
in prior work (Cronbach’s alpha ≥0.86) (J. K. Benzer et al., 2011).  
We identified our employee sample using the assigned workgroup code and an 
item indicating the service for which a respondent is primarily responsible. Because the 
AES is not collected for research purposes, several inclusion criteria were applied to 
ensure appropriate respondents. First, we only included workgroups that were 
designated by the local AES coordinator in each medical center as primary care or 
ambulatory care. We evaluated the accuracy of the chosen workgroup names by 
calculating the percentage of respondents who indicated that they were responsible for 
primary care services. We excluded HBC with less than 50% of its respondents on 
average across time (2008–2012) indicating that they provided primary care services. 
This was necessary for the HBC workgroups because they cover more diverse health 
care tasks than CBOCs so we were concerned with referents to inappropriate 
workgroups. We excluded workgroups that combined multiple CBOCs. 
AES individual responses were selected based on occupational categories and 
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included physicians (both primary care and all sub-specialists), nurses, pharmacists and 
social workers (Table A2). These selection criteria aimed to capture the diverse 
composition of diabetes health care providers (Pham, O’Malley, Bach, Saiontz-Martinez, 
& Schrag, 2009; D. L. Weeks, Polello, Hansen, Keeney, & Conrad, 2014). 
Finally, we required a minimum of five respondents per facility. This criterion 
provided adequate intraclass correlations (ICC(1) and ICC(2)) with minimum patient 
loss. Figure A1 summarizes the AES sample evolution as the discussed inclusion criteria 
were applied. The existence of relational climate was assessed through inter-rater 
reliability (ICC(1)) before aggregating individual relational climate scores to the 
workgroup and then to the clinic level (STA5A) (Schneider, Ehrhart, & Macey, 2011). We 
also calculated the reliability of the resulting measure using the ICC(2) (Koch, 2004).  
 
Statistical Analyses 
The dataset was structured as an unbalanced hierarchical panel. Some patients 
appeared in the medical records inconsistently over time. They were clustered into 
clinics, which in turn were part of parent facilities. By combining time series of cross-
section observations, panel data leads to more accurate parameter estimates than 
cross-sectional study designs due to larger sample variability. It also accounts for the 
impact of omitted (mismeasured or unobserved) variables in the model specification 
(Gujarati, 2008; Hsiao, 2006). Correlation among observations arises from the cross-
sectional level (patients clustered within clinics and clinics within parent facilities) and the 
longitudinal level (quality measurements of the same individual across time).  
The Hausman specification test (Hausman, 1978) was conducted for all outcome 
variables including the all-or-none indicator, the number of tests and the three 
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intermediate outcome measures. In all cases, estimating the model using fixed effects 
(FE) rather than random effects (RE) was supported. The null hypothesis of 
independence between the error term and the regressors was clearly rejected (p-value 
<0.001). An important difference between FE and RE is that the latter assumes no 
correlation between unmeasured or unobservable variables and the explanatory 
variables, while FE accounts for it. FE models heterogeneity among entities (clinics in 
our case) using dummy variables, while RE conceptualizes it as a random variable that 
becomes an additional component of the error term (Gujarati, 2008; M. Park, 2010). The 
average correlation among outcome measurements of patients in the same clinic was 
0.44, in contrast to 0.07 at the parent facility level. Therefore, we only included clinic 
dummies. A two way fixed effects model with two sets of dummy variables for clinics and 
year was estimated across all models (p-value F-test of two way fixed <0.001). 
Logistic regression was used to estimate the observed association between 
relational climate and on the diabetes process indicators including the all-or-none 
measure and the number of tests. The number of tests was modeled as five separate 
binary dependent variables capturing the compliance continuum (1 vs. 0 tests and 
procedures, 2 vs. 1 or fewer, 3 vs. 2 or fewer, 4 vs. 3 or fewer and 5 vs. 4 or fewer). The 
distribution of the continuous outcome indicators, including HbA1c, LDL-C and blood 
pressure, was assessed to inform model choice. Potential transformations based upon 
Box-Cox results were evaluated when variables were not normally distributed (Box & 
Cox, 1964). An appropriate transformation to make the distribution of a variable 
approximately normal is useful because many statistical tests and intervals are based on 
the assumption of normality. Also, Generalized Linear Models (GLMs), particularly a 
Gamma model, were used to estimate continuous outcome measures that were skewed. 
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GLMs are a flexible generalization of ordinary linear regression that accommodate non-
normal distribution of the residuals (McCullagh & Nelder, 1989). The link function relates 
the mean of the dependent variable to the predictors. We used both the identity and the 
log link functions across all models. The correct specification of the link function was 
assessed with the Pregibon Link Test (Pregibon, 1980) and the choice of the distribution 
function with the Modified Park Test (Manning, Jackson, & Fusilier, 1996). Finally, the 
modified Hosmer-Lemeshow Test (Lemeshow & Hosmer, 1982) was conducted for the 
continuous models to evaluate model specification. The Hosmer-Lemeshow Test was 
not used for the large sample logistic models, as Lemeshow recommends more recently 
(Paul, Pennell, & Lemeshow, 2013a).  
Models were built in blocks. Relational climate, clinic and year fixed effects were 
included first and the rest of the variables were added sequentially in groups. The 
goodness of fit of nested models was compared using the Likelihood Ratio Test and 
Deviance over the degrees of freedom. The likelihood ratio compares the likelihood of 
the dataset under two alternative models. A ratio of the deviance to degrees of freedom 
close to 1 suggests good model fit. Models were also contrasted using the AIC Criterion. 
Model goodness of fit (calibration and discrimination) of the logistic regressions 
was evaluated through c statistics and the inspection of observed versus predicted 
values. The c statistic corresponds to the area under the Receiver Operating 
Characteristic curve (ROC), which displays the performance of a binary classifier system 
(compliance vs. non-compliance in our case) as the discrimination threshold changes. 
ROC maps the true positive rate (among those with treatment, the percentage correctly 
predicted) vs. the false positive rate (those predicted to be in the treatment group are 
observed a non-treatment prediction). A relatively large c statistic implies a high true 
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positive rate and low false positive rate. The minimum c statistic value is 0.5; the 
maximum is 1.0. Values between 0.7 and 0.8 show acceptable discrimination, values 0.8 
to 0.9 indicate excellent discrimination and models above 0.9 demonstrate outstanding 
discrimination. The concordant c statistic indicates the probability that a randomly 
selected compliant patient will have a higher predicted probability of compliance 
compared to a randomly selected non-compliant patient.  
 
Patient covariates 
Based on the conceptual framework (Figure 1.1), patient predisposing 
characteristics and enabling factors were included. Multivariable analyses adjusted for 
patient socio-demographic characteristics (age, gender, marital status and priority 
status), comorbidities and diabetes severity. Priority status includes eight categories 
indicating priority for enrollment in the VHA based on eligibility and income. We adapted 
the Elixhauser Comorbidity Software, version 3.7, to both inpatient and outpatient VHA 
data. This method adds up at the patient level diagnosed Elixhauser comorbidities based 
upon ICD-9 codes (Agency for Healthcare Research and Quality, 2011) (Table A3). 
Diabetes was not included in this counting. The number of registry categories also was 
included, which capture chronic conditions characterizing veterans’ disease prevalence 
and complexity, such as chronically mentally ill, spinal cord injury or HIV, used in making 
resource allocation determinations for VHA (Allocation Resource Center 2013) (Table 
A4). Diabetic patients with multiple comorbidities may face difficulties complying with 
their visit schedule or treatment, which may compromise quality of diabetes care (Fortin, 
Soubhi, Hudon, Bayliss, & van den Akker, 2007; Parekh AK & Barton MB, 2010). A 
dummy variable indicating whether the patient filled a prescription for insulin was also 
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included in the model as a measure of disease severity (Jackson et al., 2005). It signals 
failure of oral therapies and reflects more advanced stages of the disease (Safford et al., 
2009).  
Clinic and parent facility covariates  
Some selected variables to characterize the organizational context and group 
attitudes and behaviors part of the conceptual framework were controlled for (Figure 
1.1). 
The diabetes quality of care models adjusted for some measures of the 
organizational context including resources available to facilities, specifically, funding 
stability, full-time equivalent employees and number of beds. Funding stability was 
defined as the percentage change in the funding available to facilities between 2011 and 
2012 (Byrne, Charns, Parker, Meterko, & Wray, 2004). Also, teaching status was 
measured as the residents to bed ratio. Those facilities with a ratio above 0.25 were 
classified as teaching (J. Z. Ayanian, Weissman, Chasan-Taber, & Epstein, 1998). Quit 
rates, which indicate the percent of resignations per average onboard employee, were 
also added to the model as a proxy of employee satisfaction (Z.-X. Zhang, Hempel, Han, 
& Tjosvold, 2007). They capture the voluntary resignations (potentially preventable) and 
transfers out of the selected facility within a year (Support Service Center, 2012). Finally, 
at the clinic level, relational climate was included.  
The prevalence of diabetes care at the state level was also included as a 
measure of the organizational environment. It served as a proxy to account for patient 
selection to facilities more specialized in diabetes care. 
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Results 
Across all study years, there were a total of 1,568,180 observations. In 2010, 
327,805 patients, 212 primary care clinics and 101 parent facilities satisfied the inclusion 
criteria and were part of the study sample (Tables 2.1 and 2.2). The average age was 65 
years, most patients were men, 35% married and 35% had the highest priority status to 
access medical services. Eighty percent of diabetic patients had between 2 and 4 
diagnosed comorbidities including diabetes, 38% had a mental health diagnosis and 
close to 60% were on insulin medication. At the parent facility level, on average, the 
funding available increased between 2011 and 2012 by 2.14%, the number of beds 
available was 350, there were 2,537 full time equivalent employees, most facilities were 
non-teaching and the resignation rate was 6.36 per 100 onboard employees (Table 2.1). 
Table A5 presents the descriptive statistics for all study years. 
The percentage of diabetic patients that underwent all tests and procedures, and 
thus were guideline compliant, increased between 2008 and 2010 from 51.62% to 
56.78% and slightly decreased to 55.51% in 2012 (Table 2.2). Foot examinations are 
underreported at the VHA and, thus, were excluded from our quality measure. CPT 
codes commonly used to identify this procedure (G9226, G0245, G0246 and G0247) led 
to only 4.02% of diabetic patients having had a foot examination in 2008, which was 
considered implausible. Average HbA1c, LDL-C and blood pressure remained quite 
stable across the study period. A constant improvement in relational climate was 
observed from 2008 to 2011, indicating a better ratting of the perceptions of teamwork 
and cooperation, conflict resolution, diversity acceptance, yet it declined to 10.83 in 2012 
(Table 2.2 and Table A6). 
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Table 2.1: Patient and parent facility sample characteristics in 2010 
Patient N=327,805 
Age 65.51 (11.17) 
Male 96.44 (96.37–96.50) 
Marital Status  
Married 35.55 (35.38–35.71) 
Priority status  
Group 1 35.36 (35.20–35.53) 
Elixhauser Index   
2–4 (both included) 80.69 (80.55–80.82) 
Mental Health Diagnosis  
Yes 37.94 (37.78–38.11) 
Insulin   
Yes 59.14 (58.97–59.31) 
Parent facility  N=101 
Funding available (% change 
2012–2011) 2.14 (4.01) 
Beds available 350.18 (224.07) 
Non-teaching status  96.24 (96.17–96.30) 
Quit rate† 6.36 (1.28) 
Full time equivalent employees 2537 (1363.95) 
Diabetes prevalence (state level) 9.35 (1.21) 
Notes: †(Resignations/Average onboard employees) x100. 
Mean for continuous variables (SD); percentage for categorical 
variables (95% CI) 
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Table 2.2: Patient and clinic sample characteristics for the key study variables from 2008 
to 2012 
 
2008 2009 2010 2011 2012 
Patient a N=296,183 N=321,272 N=327,805 N=325,664 N=297,256 
All tests and 
procedures (% 
Yes) 
51.62           
(51.44–
51.80) 
56.55       
(56.38–
56.72) 
56.78       
(56.61–
56.95) 
55.89       
(55.70–
55.99) 
55.54       
(55.36–
55.72) 
LDL-C (mg/Dl) 92.49 (34.88) 
91.89 
(34.78) 
91.88 
(34.85) 
89.97 
(34.83) 
90.29 
(35.28) 
Blood Pressure              
(mm Hg)      
Systolic 133.29 (19.74) 
133.38 
(19.55) 
133.28 
(19.38) 
133.33 
(19.47) 
133.66 
(19.68) 
Diastolic 74.37 (12.53) 
74.70 
(12.54) 
74.85 
(12.46) 
75.06 
(12.45) 
75.24 
(12.50) 
HbA1c (mmol/mol) 7.37 (1.75) 7.36 (1.68) 7.39 (1.65) 7.47 (1.73) 7.50 (1.75) 
Clinics N=189 N=204 N=212 N=231 N=242 
Relational Climateb  
10.93    
(1.28) 
11.16    
(1.13) 
11.51 
(1.25) 
11.75 
(1.08) 
10.83 
(1.34) 
Notes: aMean for continuous variables (SD); percentage for categorical variables (95% CI). 
b ICC(1) captures how much the score will shift by virtue of who responds. At least 0.08 is 
required to aggregate scores from respondent to workgroup and then clinic level. ICC(1) for 
relational climate ranged from 0.09 to 0.14. 
 
Bivariate analyses using t-tests and Wilcoxon rank-sum tests between relational 
climate and the different diabetes quality measures for all study years indicated a 
statistically significant relationship (p<0.001). As described on the following sections, 
multivariate adjusted analyses suggested that relational climate is significantly related to 
processes of diabetes quality of care. However, it is not related with intermediate 
outcomes.  
 
All-or-None Model 
A one unit increase in relational climate improved the odds of undergoing all tests 
and procedures by 2% (OR=1.02, p<0.001). This result implies that patients in clinics 
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with the highest relational climate score (equal to 15) were 25% more likely to be 
diabetes guideline compliant that those clinics with the lowest relational climate score 
(equal to 4) (Table 2.3). If in 2012 all clinics had a relational climate score of at least 14, 
which corresponds to the top 5% facilities, 12,032 more diabetic veterans would have 
been guideline compliant. This estimate results from summing the additional conditional 
probability of testing if relational climate had been 14 across non-compliant patients of 
facilities with a relational climate score of 14 or lower. Notice that expected probabilities 
were calculated using each patient’s observed values of covariates. 
We also found that diabetic veterans who were married, with the highest priority 
status (one), a higher number of diagnosed comorbidities, or a mental health diagnosis 
had higher odds of being guideline compliant. Veterans below 81 years of age were 
more likely to be compliant compared to those above it. The magnitude of the difference 
peaked at the 52–57 years age group (OR=1.68, 95%CI: 1.65–1.70). Diabetic veterans 
on insulin medication, which signals a more advanced stage of diabetes, had 68% 
higher odds of undergoing all tests and procedures. Patients receiving care at a clinic 
part of a teaching parent facility were also more likely to receive better quality of care. 
Yet, quit rates had a negative relationship with diabetes quality of care. Finally, state-
level diabetes prevalence significantly increased the odds of guideline compliance. 
Selected interactions between relational climate and disease complexity and 
severity were evaluated. A statistically significant interaction was found between 
relational climate and insulin medication, indicating that relational climate had twice the 
positive observed association with quality of diabetes care (all-or-none indicator) among 
insulin-dependent veterans.  
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Table 2.3: Logistic model predicting the odds of guideline compliance  
Variablea                                 OR (95% CI)p-value 
Age (ref=Above 81 years old)  
<52 1.44(1.42–1.47)*** 
52–57 1.56(1.53–1.59)*** 
57–71 1.68(1.65–1.70)*** 
71–76 1.57(1.53–1.59)*** 
76–81 1.32(1.29–1.34)*** 
Marital Status (ref=Married) 
 Divorced, Separated or 
Widowed 1.02 (1.01–1.02)** 
Single 0.95 (0.93–0.97)*** 
Priority status (ref=Group 1)  
Group 2 0.88(0.86–0.89)*** 
Group 3 0.86(0.84–0.87)*** 
Group 4 0.8(0.78–0.82)*** 
Group 5 0.94(0.92–0.95)*** 
Group 6 0.69(0.66–0.72)*** 
Group 7 0.78(0.77–0.79)*** 
Elixhauser Index (ref=+4)  
 0 or 1 0.29 (0.28–0.29)*** 
2–4 (both included) 0.71 (0.69–0.72)*** 
Registry Categories (ref=0)  
1 0.91(0.89–0.92)*** 
2 0.71(0.69–0.73)*** 
3 0.66(0.62–0.71)*** 
4 0.59(0.47–0.75)*** 
5 0.51(0.17–1.49) 
Mental Health Diagnosis 
(ref=No) 1.04 (1.03–1.05)*** 
Insulin (ref=No) 1.68 (1.66–1.69)*** 
Relational Climate 1.02(1.01–1.03)*** 
Teaching status(ref=non-
teaching) 1.44(1.27–1.46)*** 
Quit rate† 0.11(0.08–0.15)*** 
Diabetes prevalence 1.02 (1.01–1.04)** 
Note: N=923,653. C statistic =0.69. Deviance/Degrees of 
Freedom=1.2.  a This model also adjusts for gender, number of 
beds, full time equivalent employees, which were non-significant. * 
p-value<0.05, ** p-value<0.01, ***p-value<0.001. 
†(Resignations/Average onboard employees) x100 
	32	
Model calibration was in the acceptable range (c statistic almost 0.7), suggesting 
that our treatment compliance model was able to discriminate well between those who 
underwent all tests and procedures and those who did not. We also computed the 
observed versus predicted likelihood of guideline compliance by decile and most of the 
observed over predicted ratios were close to 1 (Table A7). 
 
Number of Tests and Procedures Models 
Results suggest that relational climate contributes achieving 5 or 4 tests and 
procedures compared to fewer (OR=1.02, p-value<0.001) (Table 2.4). Relational climate 
was not associated with lower levels of testing.  Age, priority status, comorbidities, a 
mental health diagnosis or insulin medication also increased the odds of having 4 or 5 
tests compared to fewer. However, a higher registry category was negatively related to 
the odds of having 4 vs. fewer than 4 tests, but positively related to the odds of 5 vs. 
fewer than 5. Teaching status and diabetes prevalence showed a similar pattern. 
Resignation rates consistently reduced the odds of more testing, particularly in achieving 
the 5 tests and procedures. 
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Table 2.4: Logistic models predicting the odds of having 4 tests and procedures vs. 
fewer and 5 vs. fewer 
 
4 tests and 
procedures vs. fewer 
5 tests and procedures 
vs. fewer 
Variable OR (95% CI), p-value 
Age (ref=Above 81 years old)     
<52 1.51 (1.46–1.56)*** 1.56 (1.53–1.59)*** 
52–57 1.5 (1.47–1.54)*** 1.68 (1.65–1.70)*** 
57–71 1.39 (1.35–1.43)*** 1.57 (1.53–1.59)*** 
71–76 1.22 (1.18–1.25)*** 1.32 (1.29–1.34)*** 
76–81 1.39 (1.36–1.44)*** 1.44 (1.42–1.47)*** 
Gender (ref=male) 1.04 (1.01–1.09)* 1.02 (0.99–1.04) 
Marital status (ref=Married)     
Single 1.02 (0.99–1.05) 0.95 (0.94–0.97)** 
Priority status (ref=Group 1)     
Group 2 0.88 (0.85–0.91)*** 0.88 (0.86–0.89)*** 
Group 3 0.88 (0.86–0.90)*** 0.86 (0.84–0.87)*** 
Group 4 1 (0.98–1.02) 0.8 (0.78–0.818)*** 
Group 5 0.81 (0.76–0.85) 0.94 (0.92–0.95)*** 
Group 6 0.80 (0.76–0.85) 0.69 (0.66–0.72)*** 
Group 7 0.86 (0.84–0.88) 0.78 (0.77–0.79)*** 
Elixhauser Index (ref=+4)      
0 or 1 0.28 (0.27–0.29)*** 0.29 (0.28–0.29)*** 
2–4 (both included) 0.73 (0.71–0.75)*** 0.71 (0.69–0.72)*** 
Registry Categories (ref=0)     
1 1.17 (1.14–1.2)*** 0.91 (0.89–0.92)*** 
2 1.21 (1.15–1.27)*** 0.71 (0.69–0.73)*** 
3 1.34 (1.01–1.27)* 0.66 (0.62–0.71)*** 
4 1.20 (0.83–1.73) 0.59 (0.47–0.75)*** 
Mental Health Diagnosis 
(ref=No) 1.15 (1.13–1.7)*** 1.04 (1.03–1.05)*** 
Insulin (ref=No) 1.98 (1.95–2.01)*** 1.67 (1.65–1.68)*** 
Relational Climate 1.02 (1.01–1.03)*** 1.02 (1.01–1.03)*** 
Teaching status(ref=non-
teaching) 0.73 (0.65–0.81)*** 1.36 (1.27–1.46)*** 
Quit rate† 0.67 (0.37–1.19) 0.11 (0.1–0.15)*** 
Diabetes prevalence 0.96 (0.94–0.98) 1.02 (1.01–1.04)*** 
Note: N=923,653. C statistic: 0.68 and 0.69 for 4 tests and 5 tests respectively. This 
model also adjusts for number of beds and full time equivalent employees, which were 
non-significant. * p-value<0.05, ** p-value<0.01, ***p-value<0.001. 
†(Resignations/Average onboard employees) x100 
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Alternative process-based quality indicators and modeling approaches 
corroborated the positive observed association between relational climate and quality. 
An ordered (cumulative) logit model with the number of tests as the dependent variable 
was estimated. An increase in one unit in relational climate improved the odds of having 
5 compared to fewer than 5 tests and procedures part of diabetes care (complete results 
are available upon request, OR=1.03, p-value<0.0001). However, the proportional odds 
assumption did not hold indicating that separate parameters for each category of the 
dependent variable are needed (p-value<0.001). A multinomial logit was then estimated. 
A positive and statistically significant coefficient for relational climate was found again. 
Specifically, the OR of the 5-pair comparisons for relational climate were the following: 
None vs. 5 tests: 0.96 (95% CI: 0.91–0.99), 1 vs. 5: 0.92 (0.89–0.94), 2 vs. 5: 0.94 
(0.93–0.95), 3 vs. 5: 0.97 (0.96–0.98) and 4 vs. 5: 0.99 (0.99–1.01). However, these 
results should be interpreted with caution as the independence of irrelevant alternative 
assumption did not hold. A nested logit or a probit model could have been the next 
exploratory steps. A nested logit would have required establishing an ordering among 
the tests and procedures based on expert opinion reflecting their importance for diabetes 
care, which was beyond the scope of this dissertation. A probit model was rejected as a 
feasible alternative given the complex interpretation of the results and the applied nature 
of this research. Therefore, separate ordered logit models were estimated (Table 2.4). 
 In conclusion, we observed that relational climate is positively associated with 
quality of diabetes care, which seems to be consistent across different quality measures 
and estimation techniques. 
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Intermediate Outcomes Models  
LDL-C showed a skewed distribution. The Park Test supported the choice of the 
Gamma distribution. Box-Cox results identified the log as the appropriate transformation. 
Both the Gamma model and a logged model estimated with ordinary least squares 
(OLS) were assessed and led to comparable parameter estimates. Both diastolic and 
systolic blood pressures were normally distributed. Accordingly, no transformation was 
required and both models were estimated using OLS. Finally, HbA1c had a skewed 
distribution, yet the Park Test did not support the Gamma distribution (see Figure A3 for 
all the distributions). Box-Cox results signaled the log as the appropriate transformation, 
which was estimated with OLS.    
Relational climate was non-significant across the four models (Tables A8–A10).  
Women compared to men had on average lower blood pressure and HbA1c, but higher 
LCL-C levels. Patients who were single showed higher recordings for all intermediate 
outcomes than those who were married, which signals the importance of social support. 
A higher priority group was related to better outcomes for blood pressure and 
cholesterol, while diagnosed comorbidities besides diabetes worsen HbA1c results. The 
prevalence of diabetes at the state level was a significant variable in all models. 
 
Discussion and Conclusions 
Relational climate facilitates guideline compliance with diabetes processes of 
care. We found that patients receiving care from clinics with the highest relational 
climate score had a 25% greater likelihood to undergo all diabetes tests and procedures 
than those in clinics with the lowest relational climate scores. If these results generalize 
to the population, and we assume that all clinics had in 2012 a relational climate of at 
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least 14, 12,000 more veterans would have been diabetes guideline compliant. 
Relational climate also is important for insuring the full set of tests relative to fewer tests 
and procedures. Our findings indicate that relational climate has twice its positive 
influence on insulin-dependent diabetic patients. This complex-needs group is at a 
higher risk of diabetes complications such as kidney disease, nephropathy or stroke. 
They may receive care from a more diverse group of providers than non-insulin-
dependent patients, which increases the risk of care fragmentation. However, relational 
climate does not contribute to explaining diabetes intermediate clinical outcomes (LDL-
C, blood pressure and HbA1c); they seem to be driven by patient factors such as 
disease severity and complexity.  
This is one of the first studies reporting a positive observed association between 
the interpersonal environment and guideline-based care in chronic disease 
management. Benzer and colleagues found similar results using a cross-sectional 
sample of 4,539 veterans in 2007 and measuring processes of diabetes care through 
binary indicators for each test and procedure (J. K. Benzer et al., 2011). Outside the 
VHA system, Bosch and colleagues assessed the relationship between team climate 
and quality of diabetes care in 30 primary care practices. Team climate was measured 
using the Team Climate Inventory, which evaluates shared employee perceptions on the 
decision making environment, support for innovation, team processes, task orientation, 
organizational objectives and value of teamwork. No significant association was reported 
between team climate and quality (Bosch, Dijkstra, Wensing, van der Weijden, & Grol, 
2008). However, this study was based upon a relatively small sample size. Bower and 
colleagues used the same climate measure but on a larger representative sample of 42 
practices in England. They concluded that a stronger team climate contributed to better 
	37	
diabetes quality of care and higher patient satisfaction (Bower, Campbell, Bojke, & 
Sibbald, 2003). Previous research found that the relational dimension of organizational 
climate is predictive of diabetes quality of care, but the task-oriented one (i.e. focus on 
performance goals and improvement) is not (J. K. Benzer et al., 2011). Our study 
complements previous research by focusing on the interpersonal domain of the work 
environment, using a 5-year timeframe and alternative quality measures.  
We also found that married veterans were more likely to be guideline compliant 
than single ones, which is consistent with prior research underscoring the importance of 
social support to diabetes management (T. A. Miller & DiMatteo, 2013; Schiøtz, 
Bøgelund, Almdal, Jensen, & Willaing, 2012). Second, diabetic patients receiving care at 
teaching facilities were more likely to undergo all recommended processes of diabetes 
care. Existing literature mostly concurs that higher quality of care is provided at teaching 
facilities (Ayanian & Weissman, 2002). Third, an increase in resignation rates 
undermines guideline-based care. We found a highly significant and relatively large odds 
ratio (OR=0.11, 95% CI 0.08–0.15). Employee resignation is a proxy for employee 
satisfaction and it may signal dysfunctional organizational processes such as excessive 
workloads or poor communication (Davidson, 2009; Mohr, Burgess, & Young, 2008). 
Also, it requires searching for and training of new personnel, which may temporarily 
weaken human capital resources. As a result, continuity of care may be interrupted and 
quality of diabetes care compromised. Future research should explore how quit rate is 
associated with quality of care in other chronic conditions and also how it may influence 
(or be influenced by) measures of the work environment such as relational climate. 
There are several limitations to our analysis. First, the all-or-none indicator built 
to measure processes of diabetes quality of care assigns the same weights to all its 
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components. Even though assessing cholesterol, blood pressure, HbA1c levels, and 
conducting eye examination and nephropathy screening are broadly considered as 
indisputable basis of diabetes care, their relative importance may vary by patient. Future 
research may study the effects of partial test compliance to build quality measures 
assigning partial credit across the compliance continuum. Another shortcoming of the all-
or-none indicator is that it classifies as non-compliant both patients without any tests and 
those that had some. To overcome this limitation, we also explored the number of tests 
as an alternative quality measure. Results suggest that relational climate facilitates 
completing 4 or 5 tests compared to fewer tests.  Second, the generalized 
underreporting of foot examinations at the VHA limited our availability to build a more 
complete all-or-none quality indicator. Since the VHA only bills private insurance 
companies for a small proportion of dually covered veterans, CPT billing codes are not 
necessarily collected and coded consistently and completely. Fifty-two to fifty-seven 
percent of diabetic veterans part of our study sample underwent all tests and procedures 
recommended by the ADA excluding foot examination between 2008 and 2012. 
Therefore, the percentage of fully complaint patients (including foot examination) is 
probably lower. Third, another source of bias stems from dually eligible veterans for VHA 
and Medicare health care services. Our sample resulted from rather conservative 
inclusion criteria (2 diabetes diagnoses rather than one) and, thus, it aims to include 
veterans using the VHA as their main source of diabetes care. Fourth, the timeframe of 
our analysis, 5 years, may not be long enough to capture fully the influence of relational 
climate on the organization. Also, FE only account for time-invariant unobserved or 
unmeasured variables. Some time variant unmeasured factors influencing the 
regressors and quality of diabetes care may still bias our results, such as measures of 
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patient access to healthcare services beyond priority status or social support. However, 
this is one of the first longitudinal retrospective data analyses assessing the influence of 
organizational variables on quality of diabetes care. It provides preliminary evidence of 
the importance of relational climate to diabetes care that future research should validate 
using a longer time frame and a different setting outside of the VHA. Fifth, there was a 
deterioration of the AES response rate across the study period. The observed decline in 
relational climate in 2011 could capture a true worsening of the work environment or 
selection bias. Dissatisfied employees may be more willing to complete the AES than 
relatively satisfied employees who may suffer from survey fatigue. Future work should 
explore the more recent evolution of relational climate and whether the positive 
association with quality of diabetes care found in this study holds. Finally, the benefits of 
a strong relational climate should be explored in other conditions requiring integrated 
and coordinated care such as cancer, heart disease or dementia. 
In conclusion, relational climate as it affects the teams of medical providers is a 
robust predictor of guideline-based care. It may influence organizational readiness and 
clinician behavior to implement quality improvement strategies such clinical pathways, 
information technologies and new evidence-based treatments successfully. As the 
model of patient-centered medical home disseminates through the health care system, 
strong relational climate could serve as a strategic asset for healthcare organizations to 
provide high quality primary care particularly among patients with chronic conditions.
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CHAPTER 3: RELATIONAL CLIMATE AND COSTS OF DIABETES CARE 
 
Background  
A strong relational climate may foster cost-saving behaviors related to better 
team functioning. However, its association with health care costs remains unexplored. 
Existing research indicates that teamwork contributes to efficient resource allocation and 
lowers costs (Curley et al., 1998; Ettner et al., 2006; Ingram & Desombre, 1999; Risser 
et al., 1999; Wade & Kleiner, 1998; Zwarenstein et al., 1996). Risser and colleagues 
estimated that better team functioning, resulting from improved communication and 
coordination, reduced medical errors and saved nearly $345,460 per 100,000 
emergency department visits. Along similar lines, Zwarenstein and Bryant concluded 
based on a literature review that better collaboration between nurses and doctors helped 
control health care costs. However, whether relational climate, a broader measure of 
organizational context, is related to costs is unknown. 
This chapter aims to assess the observed influence of relational climate in 
primary care on health care costs incurred by diabetic patients between 2008 and 2012 
differentiating among outpatient, inpatient and total costs. Analyses were conducted at 
the patient level and accounted for inter-temporal and cross-section correlation arising 
from panel data and clustering of patients within clinics. The disease-specific cost 
analysis is motivated by observed resource use differences across medical conditions. 
This approach may facilitate building a risk adjustment model tailored to diabetes care 
that minimizes confounding. We hypothesize that relational climate is negatively 
associated with costs. A strong relational climate may facilitate integrated and 
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coordinated care, which may reduce the frequency and intensity of both outpatient and 
inpatient medical care. 
 
Conceptual framework 
We postulate that health care teams are built around the medical needs of 
individual patients (Bradford, Kleit, Krousel-Wood, & Re, 2001). Diabetic patients receive 
care from different providers based on their disease severity and comorbid complexity. 
The diabetes health production function captures the relationship between inputs used in 
the provision of diabetes care (such as primary care visits and tests performed) and 
output (patient’s health). It can be formalized as follows: 𝐻! = 𝑓 𝐿! ,𝐾! ,𝑋!  
 
where patient i health depends on labor (L), which is the amount of time spent by 
providers with patient i, capital (K) including equipment used and tests performed, and 
patient characteristics (X). Decreasing returns to scale in L and K of the diabetes care 
production function are assumed, which implies that when L or K increase, health 
improves but at a decreasing rate. 
We hypothesize that stronger relational climate enhances the effectiveness of the 
use of labor. Cooperation improves among team members and better care is delivered. 
As a result, the diabetes care production function shifts up indicating better health at 
each level of labor and lower costs are observed (the marginal cost shifts down) (Figure 
3.1). 
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Figure 3.1: Hypothesized influence of relational climate on the production function and 
costs of diabetes care 
 
 
  The dual of the production function is the cost function. We postulate that 
relational climate influences cost through quality and effort. It can be formalized as 
follows (Bradford et al., 2001; Gutacker et al., 2013):  𝐶! = 𝑓(𝑋! , 𝑞! , 𝑟! ,𝑤! , 𝑒!) 
where Ci represents health care costs of diabetic patient i, X is a vector of individual  
patient characteristics, q is quality of care, r is the price vector for capital, w is the price 
vector of labor and e the effort exerted by providers at clinic c. 
Providers in organizations with stronger relational climates may exert more effort 
into delivering care than those in organizations with weaker climates. They may be more 
motivated in a work environment with a stronger spirit of cooperation and teamwork, 
fairer resolution of conflicts, and broader difference acceptance. Similarly, organizations 
with stronger relational climate might tailor care better to patient needs, leading to higher 
quality of care. Cooperation and teamwork may facilitate treatment design, execution, 
and evaluation by avoiding unnecessary duplication of work, facilitating fluent 
∆	
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communication among providers and making visits more efficient in addressing patient 
needs. 
 
Methods 
The study sample inclusion criteria and the assignment of patients to clinics was 
the same as described in chapter 2.  
Costs of diabetes care 
Cost data were obtained from the VHA Managerial Cost Accounting (MCA) 
national data abstracts. The VHA accounting and cost allocation system is based on 
VHA defined Relative Value Units (RVU). Unlike charges, RVUs capture the estimated 
relative costs of resources needed to produce a given service. Each department’s total 
intermediate product expenditures per RVU are calculated by multiplying the department 
cost per RVU by the assigned intermediate product RVUs. Total outpatient or inpatient 
costs are the result of combining fixed direct costs (including administrative functions 
and supervision directly related to the care provided), fixed indirect costs (facility utilities, 
headquarters, national and VISN support, which are not directly related to patient care) 
and variable direct costs which fluctuate with the volume and intensity of resources used 
during patient care.  
Costs were adjusted for inflation using the Producer Price Index for General 
Medical and Surgical Hospitals assembled by the Bureau of Labor Statistics(Bureau of 
Labor Statistics, U.S. Department of Labor, 2010).  We accounted for regional labor cost 
differences using the Centers for Medicare and Medicaid Services (CMS) Medicare 
Wage Index adjusted for VHA market areas (T. H. Wagner, 2012).  
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Explanatory Variables 
Besides relational climate, other explanatory variables included patient 
characteristics such as age (Schneider EL & Guralnik JM, 1990), gender (Owens, 2008), 
marital status as a proxy of social support (Cabrera-Alonso, Long, Bangalore, & Lescoe-
Long, 2003), whether the patient is on insulin medication as a measure of diabetes 
severity, and Nosos risk scores. Nosos risk measures are a weighted composite of 
hierarchical condition category (HCC) risk scores, age, gender, priority status, VHA 
chronic care registry categories and pharmacy utilization. Weights are determined by a 
regression predicting annual VHA patient costs (T. Wagner, Stefos, Moran, & Cashy, 
2015).  
The all-or-none quality indicator capturing ADA guideline compliance was also 
incorporated as an explanatory variable. The number of tests administered to diabetic 
patients also was assessed as an alternative quality indicator. It was included as a 
categorical variable and it provided more granular information on the compliance status 
of the patients. 
We also controlled for the teaching status of the parent facility. Existing literature 
concludes that teaching facilities incur significantly higher costs than non-teaching. This 
difference stems from the provision of medical education, higher wages and higher 
patient complexity (Koenig et al., 2003; US Department of Agriculture, 2014).  
The population size of the clinic’s surrounding area, categorized as urban or 
rural, was obtained by mapping clinic ZIP code to Rural Urban Commuting Area 
(RUCA). Previous research suggests that rural areas have higher morbidity, greater 
anticipated services needs and higher costs than urban areas (Blazer, Landerman, 
Fillenbaum, & Horner, 1995; W. B. Weeks et al., 2004). A variable accounting for 
	45	
regional variation in wage structure was added to the cost model as well (T. H. Wagner, 
2012). Finally, relational climate was the key independent variable of interest across the 
cost models. 
 
Statistical analyses 
The Hausman Test, the Breusch-Pagan Test and the F-test were used to choose 
between FE and RE.	In our case, the null hypothesis of the Hausman Test was clearly 
rejected and, thus, FE were employed (p<0.001). Across the outpatient, inpatient and 
total cost models we included two-way FE dummy variables, which implies a separate 
intercept for each clinic and year.  
Annual patient costs were highly right-skewed and kurtotic. Outliers may reflect 
measurement errors or originate from a different population than the rest of the sample. 
They complicate model estimation by increasing the error variance, altering the 
probability of Type I and Type II errors and biasing parameter estimates (Osborne & 
Overbay, 2004). Accordingly, the most extreme observations were top-coded or deleted. 
Annual total outpatient costs above $1 million or annual inpatient costs superior to $3 
million were top-coded to $1 and $3 million respectively. Values below $20 for outpatient 
and $1,000 for inpatient costs were deleted. Also, observations with an absolute 
studentized residual above 3.5 were deleted as well. Data cleaning led to a loss of 2% of 
our sample.  
After data cleaning, outpatient, inpatient and total costs distributions were still 
right-skewed. We undertook estimation following two approaches. The first one engages 
the panel data using Ordinary Least Squares (OLS) with clinic and year fixed effects. 
OLS estimation fails to deal adequately with skewed data, which can lead to overfitting. 
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OLS minimizes the sum of squared residuals, a technique that tends to overemphasize 
the influence of extreme observations. Using Box-Cox (Box & Cox, 1964), we identified 
the logarithmic transformation as the most suitable to estimate outpatient, inpatient and 
total cost in the OLS environment. The logarithmic transformation is commonly used to 
make the distribution of the residuals more symmetric and closer to normality. The 
general log regression model is characterized as follows: ln 𝑦! = 𝑋!β+ ε! 
where X represents a vector of independent variables and ε the error term for individual 
i. It assumes that Cov(X,ε)=0 and E[ε]=0.  
A log-transformed OLS model however poses the challenge of re-transformation 
to the original or raw scale of the dependent variables for purposes of inference and 
parameter interpretation. Exponentiating both sides of the logged regression model and 
then taking the conditional expectation, we have: 𝑦! = 𝑒!!!!!! 𝐸 𝑦! 𝑥 = 𝐸 𝑒!!!!!! = 𝐸 𝑒!! 𝐸[𝑒!!] 𝐸 𝑦! 𝑥  is the conditional exponentiated mean and 𝐸 𝑒!!  is the exponentiation 
factor. We considered four models of retransformation to the raw scale to find 𝐸 𝑦! 𝑥 , 
depending on the distribution (normal vs. non-normal) and variance (homoscedastic vs. 
heteroscedastic) of the residuals. Visual exploration, the Kolmogorov-Smirnov test for 
normality and the White Heteroscedasticity Test indicated the existence of non-normally 
distributed but homoscedastic residuals across the three OLS models (Figure B1). 
Consequently, re-transformation to the raw scale using the classical Duan smearing 
adjustor was conducted (Duan, 1983). 
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The second approach relied on a Generalized Linear Model (GLM) based on the 
Gamma distribution with clinic and year fixed effects. The Gamma distribution has a 
variance proportional to the mean. If used when predicting costs, it implies that more 
variability in medical expenditures should be observed among patients with observed 
higher costs.  
The influence of relational climate on outpatient, inpatient and total cost was 
estimated using the empirical model specified as follows:  𝐶!" = 𝛼 + 𝛽𝑋!" + 𝛿𝐿!! + 𝜑𝑃!" + 𝐾! + 𝑌! + 𝜀!" 
where Cit are the costs incurred by diabetic patient i in year t, X is a vector of patient 
characteristics, L includes clinic (c) level variables such as relational climate and P is a 
vector of parent facility (p) level characteristics . In the GLM model, costs were specified 
as 𝑙𝑛𝐸[𝐶!"],, while in the logged model as 𝑙𝑛𝐶!". K and Y are clinic and year dummies 
respectively. 𝜀!" is the error term. Both the GLM and the OLS model were specified with 
the same covariates including an intercept. 
The adequacy of the Gamma distribution and the log link were evaluated using 
the modified Park test and the Pregibon Link test. The modified Park test (R. E. Park, 
1966) considers the case where the variance is assumed to follow a power relationship 
to the mean.  
In general,  𝑉 𝐶𝑜𝑠𝑡 𝑥 = 𝛼 𝜇 𝐶𝑜𝑠𝑡 𝑥 ! 
where α is a constant indicating the degree of over (α>1) or under (α<1) dispersion and λ  
is also a constant guiding the choice of the distribution function. µ indicates the mean 
function. For λ=0, a Normal distribution is supported. For λ=1, a Poisson distribution is 
supported as the variance of the costs are a multiple (α) of the mean (µ). For λ=2, a 
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Gamma distribution is suggested with the standard deviation proportional to the mean. 
The log of the raw-scale residuals squared is regressed on the log of the raw-scale 
prediction, (𝜇). The significance of the coefficient of log(𝜇)  is assessed based on t-tests.  
The Pregibon’s link test is a two-step test conducted on the estimation scale of 
the link function. The first step creates predicted costs based on the coefficients of the 
full model. The second stage uses the same distribution and link function as in the first 
stage but it adds the squared predicted costs as a regressor. If the data follow a linear 
formulation under the link function as specified, the coefficient of the squared prediction 
term should be non-significant.  
The goodness of fit of the OLS and GLM Gamma cost models was assessed 
through the modified Hosmer-Lemeshow (H-L) Test. It is a diagnostic variant of the H-L 
test for checking the fit of logistic models. The modified H-L test determines the 
existence of prediction bias over the range of the covariates or the predicted values. 
When the model is properly specified, the residuals on the estimation scale should be 
random without exhibiting systematic patterns. The H-L test estimates the full model and 
predicts the conditional raw scale mean costs for each case. Raw-scale residuals are 
then created along with a set of indicator flags for deciles of the predicted raw-scale 
costs. The raw-scale residuals are regressed on these ten flags suppressing the 
intercept, using robust Huber/White estimators of the variance-covariance matrix to 
correct for heteroscedasticity. The ten estimated coefficients should be jointly 
insignificant using an F-test to conclude that the model is appropriately specified.  
OLS and GLM Gamma models also were compared on the basis of mean 
prediction error, mean absolute predictive error and predictive error ratios (actual to 
predicted costs) across cost quintiles using a fifty percent validation sample. The mean 
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absolute predictive error is an average of the absolute errors and captures bias in the 
individual observations. The mean prediction error averages the residuals and evaluates 
bias in the overall sample. Predictive error ratios help to identify the source of bias by 
comparing predictive and observed costs across quintiles of the dependent variable. 
Predictive error ratios above one signal overprediction. 
 
Results 
Table 3.1 presents the variables unique to the cost model and, thus, not 
presented in Tables 2.2, 2.3 or A5. Outpatient median costs incurred by diabetic patients 
increased by 19% across the study period, from $5,481 in 2008 to $6,538 in 2012. 
Inpatient median costs rose by 5% from 2008 to 2011 but dropped in 2012 to $15,494. 
(Figure B2). Around thirty percent of the patients used inpatient services during the study 
period. They were on average older (66.5 years vs. 65 years) and sicker (higher Nosos 
score, 5.73 vs. 1.11) compared to those without inpatient visits based on bivariate 
analyses (two sample t-test and chi-square tests p<0.001).  
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Table 3.1: Patient and clinic sample characteristics unique to the cost models 
 
2008 2009 2010 2011 2012 
Patient N=296,183 N=321,272 N=327,805 N=325,664 N=297,256 
Nosos Risk Score 2.68 (3.56) 2.63 (3.47) 2.63 (3.44) 2.72 (3.52) 2.87 (3.61) 
Chronically Mentally Ill 
(% Yes) 
1.24          
(1.20–1.28) 
1.27         
(1.23–1.31) 
1.28         
(1.24–1.32) 
1.26         
(1.22–1.30) 
1.38          
(1.34–1.42) 
Outpatient Costs† $9,324.25 ($5,412.16) 
$9,566.41 
($5,448.19) 
$9,834.99 
($5,719.63) 
$10,423.09 
($6,127.67) 
$10,831.28 
($6,428.04) 
Inpatient Costs† $32,162.27 
($14,912.17) 
$33,492.73 
($15,142.02) 
$34,165.86 
($15,519.06) 
 
$34,412 
($15,941.54) 
$33,168.09 
($15,277.22) 
Total Costs† $20,808.98 ($6,877.09) 
$21,082.71 
($6,786.01) 
$21,759.73 
($7,212.08) 
$22,773.63 
($7,802.75) 
$23,737.96 
($8,636.83) 
Clinic N=189 N=204 N=212 N=231 N=242 
Urban/Rural (% Rural) 5.97         (5.88–6.06) 
5.68         
(5.60–5.76) 
5.74        
(5.66–5.82) 
5.36         
(5.28–5.44) 
5.36          
(5.28–5.45) 
Notes: Mean for continuous variables (SD); percentage for categorical variables (95% CI). † The mean, and 
the median in parenthesis, are presented given their skewed distribution. 
 
Regression results 
The Modified Park test supported the Gamma distribution for the three GLM cost 
models (Table B1). The ratio of actual to predicted costs seems to conform to a Gamma 
distribution (Figure B3).  The log link was chosen as it led to model convergence (unlike 
the inverse or the identity links) and it was practically supported by the Pregibon Link 
test in a gamma distributed environment (Table B2). The parameter estimates of the log-
link GLM Gamma and the log-transformed OLS models were comparable (Tables 3.2–
3.4). In general, the GLM model provided more conservative parameter estimates than 
the OLS model. The only main difference between the two approaches arose in the total 
cost model (Table 3.4), where teaching status became non-significant rather than cost 
increasing in the OLS model.  
The results of the GLM Gamma model suggest that a one unit increase in 
relational climate reduced mean expected outpatient costs by 0.4% (Mean Ratio=0.996, 
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p<0.001) (Table 3.2), which represents expected outpatient cost savings of $41 per 
diabetic patient in 2010 (average of $42.511 across the study period). In 2010, relational 
climate scores ranged from close to 7 to 15. Clinics with the strongest relational climate 
were expected to save $334 per patient on average in outpatient costs compared to 
those with the lowest score. The expected total outpatient cost saving if all clinics at 
least had the top five percent relational climate score (14) in 2010 was $20 million. 
Table 3.2: Outpatient cost results-Gamma Log-Link vs. OLS logged costs 
 
Outpatient Costs (N=914,979) 
Control 
Gamma Log-Link† OLS Logged Costs‡ 
Age (ref=65–74 years) 
  <55 years 0.0015                        (-0.003, 0.006) 
0.007  
(0.002, 0.012)** 
55–64 years -0.013                           (-0.017, -0.009)*** 
-0.007                         
(-0.011, -0.004)*** 
>75 years -0.092                             (-0.096, -0.08)*** 
-0.104                            
(-0.109, -0.099)*** 
Gender (ref=male) 0.131                        (0.123-0.137)*** 
0.149              
(0.139, 0.156)*** 
Marital Status (ref=not married)   
Married 0.023 (0.021,0.026)*** 
0.031  
(0.028, 0.034)*** 
Enrollment Priority                     
(ref=groups 4–6)   
Groups 1–3 0.061                      (0.057, 0.063)*** 
0.063                  
(0.059, 0.066)*** 
Groups 7 -0.111                          (-0.115, -0.107)*** 
-0.112                           
(-0.117, -0.107)*** 
Log of Nosos Risk Score 0.755                  (0.753, 0.756)*** 
0.728  
(0.727, 0.731)*** 
Chronically Mentally Ill (ref=no) 0.146                        (0.134-0.157)*** 
0.251                   
(0.238, 0.264)*** 
Insulin (ref=no) 0.094                   (0.091, 0.097)*** 
0.135   
(0.132, 0.138)*** 
																																																								1	The expected cost for each patient was computed (A). (A) was multiplied by the MR and (B) was obtained. 
The difference between (A) and (B) was then averaged across the patients in our sample. 	
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Quality all-or-nothing  (ref=no) 0.277                        (0.274, 0.279)*** 
0.372                
(0.369, 0.375)*** 
Relational Climate -0.004                        (-0.006, -0.003)*** 
-0.004                         
(-0.006, -0.002)*** 
Teaching status (ref=non-
teaching) 
-0.047                            
(-0.069, -0.026)*** 
-0.0631                        
(-0.087, -0.038)*** 
Notes: †Log of Mean Ratios (95% confidence intervals). To obtain mean ratios, the 
coefficients need to be exponentiated. ‡ Maximum Likelihood estimates. To obtain 
odds ratios, the coefficients need to be exponentiated. 
The model also adjusts for rural/urban (non-significant) and the wage index*** p-
value<0.001, ** p-value<0.01, * p-value<0.05 
 
 Relational climate was not associated with observed inpatient costs, yet it 
contributed to lower total costs. Specifically, a one unit increase in relational climate 
decreased mean expected total costs by 0.2% (Mean Ratio=0.998, p<0.01), which 
involves an expected total cost saving of $43.57 per patient in 2010 (average of $45.57 
across the study period). Total expected cost savings per patient between clinics with 
the highest relational climate score compared to those with the weakest score was $345. 
Finally, the expected overall total cost saving if all clinics had at least a relational climate 
score of 14 in 2010 was $21 million.   
Table B3 presents the inpatient cost parameter estimates resulting from a GLM 
Log-Link model if 2012 data was dropped. The results remained stable and, thus, the 
slight decrease in inpatient costs in 2012 did not alter our results.  
 
 
 
 
 
 
	53	
Table 3.3: Inpatient cost results- Gamma Log-Link vs. OLS logged costs 
 Inpatient Costs (N=329,214) 
Control Gamma Log-Link† OLS Logged Costs‡ 
Age (ref=65–74 years)   
<55 years -0.066                         (-0.076,-0.055)*** 
-0.055                                 
(-0.066,-0.043)*** 
55–64 years -0.057                                 (-0.065,-0.049)*** 
-0.054                                 
(-0.063,-0.046)*** 
>75 years -0.053                                  (-0.061,-0.044)*** 
-0.039                                
(-0.048,-0.029)*** 
Gender (ref=male) -0.099                                     (-0.116,-0.083)*** 
-0.104                             
(-0.122, -0.085)*** 
Marital Status (ref=not married)   
Married -0.032                               (-0.038, -0.026)*** 
-0.042                        
(-0.048, -0.035)*** 
Enrollment Priority                     
(ref=groups 4–6)   
Groups 1–3 -0.081                                   (-0.088,-0.075)*** 
-0.105                                
(-0.113, -0.098)*** 
Groups 7 0.077                              (0.066,0.087)*** 
0.082                        
(0.071, 0.094)*** 
Log of Nosos Risk Score 1.02                               (1.02,1.03)*** 
0.993                        
(0.988, 0.998)*** 
Chronically Mentally Ill (ref=no) 0.214                          (0.196, 0.231)*** 
0.214                       
(0.194, 0.233)*** 
Insulin (ref=no) 0.032                          (0.025,0.038)*** 
0.034                        
(0.027, 0.041)*** 
Quality all-or-nothing  (ref=no) -0.121                                      (-0.127,-0.115)*** 
-0.111                                 
(-0.117, -0.103)*** 
Relational Climate 0.0001                                      (-0.003,0.004) 
0.002                              
(-0.002, 0.006) 
Teaching status (ref=non-
teaching) 
0.171                         
(0.126,0.215)*** 
0.195                          
(0.146, 0.244)*** 
Notes: †Log of Mean Ratios (95% confidence intervals). To obtain mean ratios, the 
coefficients need to be exponentiated. ‡ Maximum Likelihood estimates. To obtain odds 
ratios, the coefficients need to be exponentiated.                                                                         
The model also adjusts for rural/urban (non-significant) and the wage index. *** p-
value<0.001, ** p-value<0.01, * p-value<0.05 
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Table 3.4: Total cost results- Gamma Log-Link vs. OLS logged costs 
 Total Costs (N=921,912) 
Control Gamma Log-Link† OLS Logged Costs‡ 
Age (ref=65–74 years)   
<55 years -0.041                                (-0.045, -0.036)*** 
-0.023                               
(-0.023, -0.018)*** 
55–64 years -0.053                                (-0.057, -0.049)*** 
-0.047                                
(-0.051, -0.044)*** 
>75 years -0.075                                (-0.079, -0.071)*** 
-0.064                               
(-0.068, -0.061)*** 
Gender (ref=male) 0.027                      (0.019, 0.034)*** 
0.039                         
(0.031, 0.047)*** 
Marital Status (ref=not married)   
Married 0.0001                          (-0.003, 0.003) 
0.0005                    
(-0.003, 0.004) 
Enrollment Priority                     
(ref=groups 4–6)   
Groups 1–3 -0.014                                (0.017, 0.011)*** 
-0.005                                 
(-0.008, -0.002)*** 
Groups 7 -0.063                                      (-0.067, 0.059)*** 
-0.063                                        
(-0.067, -0.058)*** 
Log of Nosos Risk Score 1.091                                           (1.089, 1.092)*** 
1.093                             
(1.092, 1.094)*** 
Chronically Mentally Ill (ref=no) 0.075                        (0.087, 0.063)*** 
0.032                            
(0.019, 0.044)*** 
Insulin (ref=no) 0.075                                   (0.072, 0.077)*** 
0.0967                                 
(0.094, 0.099)*** 
Quality all-or-nothing  (ref=no) 0.146                                (0.143, 0.148)*** 
0.196                            
(0.193, 0.199)*** 
Relational Climate -0.002                                      (-0.003, -0.005)** 
-0.002                                  
(-0.004, -0.001)** 
Teaching status (ref=non-teaching) 0.015                                  (0.143, 0.148)*** 
0.0004                            
(-0.022, 0.023) 
Notes: †Log of Mean Ratios (95% confidence intervals). To obtain mean ratios, the 
coefficients need to be exponentiated. ‡ Maximum Likelihood estimates. To obtain odds 
ratios, the coefficients need to be exponentiated.                                                            
The model also adjusts for rural/urban (non-significant) and the wage index. *** p-
value<0.001, ** p-value<0.01, * p-value<0.05 
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Diabetic veterans between 65 and 74 years of age were more likely to face 
higher inpatient and total costs than those in other age groups. A similar pattern was 
observed for outpatient costs, but patients younger than 55 years of age incurred similar 
costs than those between 65 and 74 years. The 65–74 age group has been previously 
identified as the main VHA healthcare users (Maciejewski & Maynard, 2004). Women 
had higher outpatient and total costs than men, but lower inpatient costs. Patients who 
were married showed lower inpatient and total costs, but higher outpatient costs 
compared to single ones. A higher Nosos risk score, being chronically mentally ill or on 
insulin medication were associated with higher outpatient, inpatient and total costs.  
Guideline compliance with diabetes tests and procedures increased outpatient 
and total costs yet, interestingly, reduced expected mean inpatient costs by 11%. Similar 
results were found using the number of tests as a quality indicator (Table B4). Teaching 
facilities experienced lower outpatient costs, but higher inpatient and total costs 
compared to non-teaching ones (Tables 3.2–3.4). The higher costs incurred by teaching 
facilities has been attributed to graduate medical education programs, more intensive 
biomedical research and the maintenance of highly specialized patient care (32). 
 
Goodness of Fit 
The Gamma model showed better performance than the log-transformed OLS 
model based upon mean prediction error, mean average prediction error and predictive 
error ratios by cost quintiles across the three cost models (Tables 3.5 and 3.6). 
Specifically, for outpatient costs, the total error with the Gamma model compared to OLS 
was smaller (mean absolute error: 5,103.98 vs. 5,187.16), but GLM suffered from more 
overprediction on average (-566.34 vs. -276.01) (Table 3.5). 
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Table 3.5:  Mean prediction error and mean absolute prediction error  
  Mean 
Prediction 
Error 
Mean 
Absolute 
Prediction 
Error 
Outpatient Costs 
(N=457,245) 
OLS: Logged and 
Duan -276.01 5187.16 
GLM: Gamma, Log -566.34 5103.98 
Inpatient Costs 
(N=164,615)     
OLS: Logged and 
Duan 1803.15 20735.32 
GLM: Gamma, Log 1339.65 20742.72 
Total Costs                                 
(N=457,245)     
OLS: Logged and 
Duan -522.99 11,367.88 
GLM: Gamma, Log -511.10 10,270.13 
 
Note: Results based on a validation half the size of the study sample. Mean prediction error results 
from subtracting predicted values from observed cost values. Mean absolute prediction error is the 
average of the absolute difference between predicted and observed costs.  
 
However, the overprediction was mostly occurring at the low quintiles of the 
outpatient distribution. The GLM model led to a predictive ratio closer to 1 for the highest 
quintile (0.79 vs. 0.62), signaling less underprediction (Table 3.6). A similar comparison 
between the two modeling approaches was observed for total costs. The Gamma 
inpatient cost model showed a larger total error (20,742.72 vs. 20,735.32), but less 
underprediction on average (1,339.35 vs. 1,803.15) and better performance in terms of 
predictive ratios particularly at the highest quintile (Table 3.5).  
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Table 3.6: Predictive error ratios by cost quintiles 
Outpatient Costs 
(N=457,245) 
Lowest 
Quintile 
(<$2,033.1) 
Second 
Lowest 
Quintile 
($2,033.1–
$4,481.1) 
Middle 
Quintile 
($4,481.1–
$8,527.3) 
Second 
Highest 
Quintile 
($8,527.4–
$16,397.4) 
Highest 
Quintile 
(>$16,397.4) 
OLS: Logged costs 
with Duan’s adjustor 2.28 1.66 1.41 0.94 0.62 
GLM: Gamma 
distribution, Log link 2.76 1.37 1.14 1.18 0.79 
Inpatient Costs 
(N=164,615) 
Lowest 
Quintile 
(<$5,261.9) 
Second 
Lowest 
Quintile 
($5,261.9–
$11,031.1) 
Middle 
Quintile 
($11,031.1–
$21,371.4) 
Second 
Highest 
Quintile 
($21,371.4–
$44,792.2) 
Highest 
Quintile 
(>$44,792.2) 
OLS: Logged costs 
with Duan’s adjustor 5.02 2.57 1.60 0.72 0.38 
GLM: Gamma 
distribution, Log link 3.41 1.74 1.09 1.08 0.57 
Total Costs                                 
(N=457,245) 
Lowest 
Quintile 
(<$2,128.9) 
Second 
Lowest 
Quintile 
($2,128.9–
$5,233.8) 
Middle 
Quintile 
($5,233.8–
$12,782.3) 
Second 
Highest 
Quintile 
($12,782.3–
$32,296.2) 
Highest 
Quintile 
(>$32,296.2) 
OLS: Logged costs 
with Duan’s adjustor 1.83 1.57 1.43 1.06 0.69 
GLM: Gamma 
distribution, Log link 2.3 1.27 1.16 1.31 0.86 
Notes: Results based on a validation sample half the size of the original sample. Ratios of predicted over 
observed costs by quintile. 
 
In addition, the H-L test supported the Gamma model over OLS as lower mean 
residuals by cost deciles were observed for the three cost models (Figure B4). 	
 
Discussion and Conclusions 
Relational climate appears to contribute to lower outpatient and total healthcare 
costs of diabetic patients. A one unit increase in relational climate significantly reduced 
mean expected outpatient costs by $42 and total costs by $45 per patient on average 
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from 2008 to 2012. Our results suggest that if in 2010 all clinics had a relational climate 
score of 14, $20 million in total outpatient costs and $21 million in overall total costs 
could have been potentially saved. These findings highlight the cost saving potential of a 
strong work environment.  
However, relational climate in primary care was not associated with inpatient 
costs. A supportive primary care work environment may foster better outpatient work 
processes leading to better quality of care and lower outpatient costs. However, the 
ability of relational climate in primary care to reduce hospitalizations directly or reduce 
costs within hospitalizations seems rather limited.  
More than 50% of the clinics had a relational climate score lower than 11.2 in 
2012, which appears to signal a need to enhance interpersonal interactions. Relational 
climate can be ameliorated. Klein and Kozlowski postulate that HR practices shape 
relational climate, which in turn influences employee and organizational performance (K. 
J. Klein & Kozlowski, 2000). HR practices aimed at improving perceptions of teamwork, 
conflict resolution and diversity acceptance could reinforce relational climate. The 
weaker components of relational climate can be identified based on the AES results and 
HR practices designed accordingly. Hiring or reassigning new or existing employees, 
clarifying team goals or training staff for team-based roles are examples of HR practices 
to improve team functioning. Individual perceptions of interpersonal interactions will vary 
as new HR practices disseminate. Eventually new shared beliefs will arise and relational 
climate will change. 
We also found that quality of diabetes care is related to healthcare costs. Quality 
of diabetes care was measured using an all-or-none process of care indicator capturing 
guideline compliance. Patients that underwent all tests and procedures (HbA1c, LDL-C 
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testing, blood pressure, retinal screening and nephropathy) incurred higher outpatient 
costs but lower inpatient costs. We found similar results using the number of tests as an 
alternative process-based quality indicator. These recommended tests and procedures 
are essential to prevent or delay the development of diabetes complications and mitigate 
their severity (American Diabetes Association, 2014). Previous studies describe the 
reduction in hospitalizations related to higher quality of diabetes in primary care (Bottle 
et al., 2008; Calderón-Larrañaga et al., 2014; Kim, 2007). Calderón-Larrañaga and 
colleagues conducted a longitudinal retrospective study between 2004 and 2009 in 
England including 54 million patient observations and 8,000 general practices. Higher 
quality of diabetes care, measured as primary care access and HbA1c control, was 
related with lower hospital admission rates across most diabetes complications. Along 
similar lines, Kim, based on a U.S. representative sample of patients with uncontrolled 
diabetes, concluded that hospitalizations are influenced by patient treatment compliance, 
patient complexity (including other comorbidities besides diabetes) and the quality of 
timely and appropriate care in the community.  
Some study limitations should be acknowledged. First, all inpatient and 
outpatient costs incurred by diabetic patients were considered, a proportion of which 
correspond to other medical conditions. Attributing cost items to diabetes care is 
particularly challenging because of the disease’s systemic characteristics and the lack of 
a coding system with enough granularity. Nevertheless, our study sample only included 
patients with at least two diabetes diagnoses. The proportion of diabetes unrelated costs 
may be small. Second, the modified Hosmer-Lemeshow test highlighted the difficulties of 
accurately predicting the upper end of the cost distribution. Our results overall suggest 
that the Gamma model underpredicts the upper cost deciles, but it still performs better 
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than the OLS model. Models were assessed in relative terms based on the mean 
predictive error, mean absolute predictive error, predictive errors across cost quintiles. 
Further research should explore alternative estimation techniques to model healthcare 
costs such as quantile regression or finite mixture models as well as risk adjustment 
refinements to existing models. Quantile regression aims to estimate the conditional 
median or other quantiles of the dependent variable rather than the conditional mean in 
Ordinary Least Squares (OLS). This estimation method is more robust against outliers 
compared to OLS (Koenker & Hallock, 2001). On the other hand, finite mixture models 
combine two or more assumed distributions. Each of them explain a portion of the data 
and accommodates the presence of outliers (McLachlan & Peel, 2004). Third, there was 
a deterioration of the AES response rate across the study period from 72.8% to 63.4%. 
The observed decline in relational climate in 2011 could capture a true worsening of the 
work environment or selection bias. Dissatisfied employees may be more willing to 
complete the AES than relatively satisfied employees who may suffer from survey 
fatigue. Future work should explore the more recent evolution of relational climate and 
whether the negative association with costs of diabetes care found in this study holds. 
Finally, our results are specific to VHA patients, who mostly are men, of an older age 
and sicker than the general U.S. population. The cost saving potential of relational 
climate reported in this study needs to be confirmed using other populations and a more 
recent or longer timeframe.  
This is the first study supporting the cost saving potential of relational climate in 
diabetes care. Relational climate can serve as a strategic asset for organizations. It may 
reduce health care costs by fostering efficient team-based care delivery. Preliminary 
research suggests that the VA patient-centered medical homes improve quality of care 
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without increasing costs (S. Klein, 2011; Reid et al., 2009). Patient-aligned care teams 
define this organizational change aimed at improving patient satisfaction, healthcare 
outcomes and costs. Multidisciplinary care teams include primary care providers, 
registered and licensed nurses, a medical clerk with support of pharmacists, social 
workers, nutritionists, psychologists and disease management coaches. Its 
implementation demands substantial changes in interpersonal interactions part of care 
delivery. The VHA has allocated resources to hire additional staff and instituted 
nationwide training programs. Some challenges include building trust among team 
members, managing their expectations and aligning them with organizational goals. 
Clinics with shared perceptions of a strong collaborative environment among employees, 
fair resolution of conflict and diversity acceptance (high relational climate score) may 
experience a smoother transition into this promising care delivery system than clinics 
with problematic interpersonal environments.  
In conclusion, as organizations strive to improve care delivery and reduce costs, 
strengthening the work environment may become a necessary condition to succeed. Our 
research suggests that the work environment is related to observed costs. Relational 
climate may be a source of competitive advantage by enhancing work processes part of 
diabetes treatment design, execution, and evaluation contributing to lower costs.   
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CHAPTER 4: THE INDIRECT ASSOCIATION OF RELATIONAL CLIMATE AND 
COSTS THROUGH QUALITY 	
Chapters 2 and 3 assessed the direct association of relational climate and quality 
and costs of diabetes care. By direct association we refer to the change in quality or 
costs related to an increase in relational climate, which is captured by the parameter 
estimate of relational climate part of the quality (chapter 2) or cost (chapter 3) 
regressions. In chapter 2, a positive association between relational climate and quality of 
diabetes care (guideline compliance) was found. In chapter 3, a negative association 
between relational climate and costs was reported. Therefore, based on these two 
chapters, we conclude that relational climate contributes to guideline compliance and to 
lower outpatient and total costs. The cost models also included quality of diabetes care 
(guideline compliance) as an explanatory variable. Guideline compliance was related to 
higher outpatient costs, lower inpatient and higher total costs.  
Chapter 4 refines the cost-saving estimates of relational climate by accounting 
for the indirect association between relational climate on costs through quality (which we 
know from chapter 3 that affects costs) (Figure 4.1).  Estimating this effect requires 
information on how relational climate is associated with the probability of testing and also 
costs by compliance status. To this purpose, the quality and the cost equations are 
simultaneously estimated within a treatment-effects model to account for selection of 
patients (and/or providers) into different levels of guideline compliance.  This approach is 
new in the literature as best we know, this attempt is an effort to establish a direction for 
future research on this type of question. 
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Figure 4.1: Conceptual structure of chapters 2, 3 and 4 				
 
 
Measured and unmeasured provider, clinic and patient characteristics influence 
the probability of guideline compliance and treatment-specific outcomes (healthcare 
costs). An imbalanced distribution of these variables between guideline compliant 
(treated) and non-compliant patients might be observed, which is formally referred to as 
treatment-selection bias. In other words, compliant and non-compliant individuals may 
be systematically different even before undergoing any level of testing.  
Some of the most commonly used estimators to address treatment-selection bias 
are regression adjustment, inverse probability weighting, inverse probability weighting 
with regression adjustment (IPWRA) and matching techniques (nearest-neighbor 
matching and propensity scores matching) (Austin, 2009b, 2011; Becker & Ichino, 2002; 
Stata Corporation, 2015). We chose IPWRA as it is a double-robust estimator. IPWRA 
combines the main equation (costs) with the selection equation (the probability of 
guideline compliance) to estimate the causal effect of an exposure on an outcome. 
IPWRA yields unbiased parameter estimates as long as one of the two equations is 
specified correctly.   
Three separate IPWRA treatment-effects models were estimated for outpatient, 
inpatient and total costs. In each case, IPWRA estimates the quality (probability of 
guideline compliance) and cost equations simultaneously. Three sets of parameter 
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estimates are obtained including those for the quality equation, the cost equation under 
compliance, and the cost equation under non-compliance. After model estimation, the 
probability of guideline compliance and mean expected costs under compliance are 
computed for baseline relational climate and also calculates it as if it was one unit higher 
for all non-compliant patients.  
The indirect influence of relational climate on costs captures how mean expected 
costs change because of an increase in the probability of testing related to a higher 
relational climate. We derive an expression for the indirect and direct effects of relational 
climate based on the definition of the total effect. The total effect results from subtracting 
expected costs under guideline compliance at baseline (obtained by multiplying the 
probability of guideline compliance by the mean expected cost) from the expected costs 
of guideline compliance if relational climate increases by 1 unit.  
Finally, the indirect effect is added to the direct effect to obtain a final estimate of 
the cost implications of increasing relational climate. 
 
Background 
Selection bias arises from unrepresentative samples. The sample is not 
randomly drawn from an underlying population due to the sample design (truncation) or 
the behavior of the sampled units (self-selection bias). Truncation originates when a 
sample is built based upon a threshold defined by another variable (e.g. selecting 
patients with at least two diabetes diagnoses). The sample therefore represents a 
portion of the distribution but statistics need to be estimated for the whole distribution. 
Information on the covariates is observed for all patients but the dependent variable of 
interest may only be observed for a sample subset.  Thus, the full potential sample is not 
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observed. Self-selection bias originates when individuals select themselves into a group. 
This leads to a distorted representation of the true underlying population. In our case, we 
are interested in understanding the interplay between quality and costs of diabetes care. 
Quality is measured through a binary indicator capturing guideline compliance. Higher 
(or lower) costs may be observed among compliant patients. Because of self-selection 
(by the patient or the provider), there may be a number of differences between compliant 
and non-compliant patients, such as disease severity, having a usual source of care, 
patient education, continuity of care or care fragmentation at the clinic where patients 
seek care, among others. As a result, a significant difference in costs could be observed 
between the two groups independent of the ability of guideline compliance to affect 
higher or lower costs. Also, self-selection bias often arises in surveys with voluntary 
participation. For example, participation in patient satisfaction questionnaires may be 
motivated by outlier care experiences (really good or bad). The resulting scores will 
misrepresent the actual patient satisfaction with care if all patients would have 
responded. 
Unlike cross-sectional studies, selection bias usually is considered a less urgent 
methodological concern when using panel data. However, panel data techniques such 
as fixed or random effects models only partially alleviate selection bias (Vella, 1998; 
Winship & Mare, 1992). In our case, we estimate fixed effects models with panel data. 
The fixed effects (FE) panel data estimator was supported by the Hausman Test for both 
the quality and the cost models (see pages 22 and 44). FE may mitigate selection bias 
when the unobserved determinants of selection are time invariant, meaning that they do 
not change across the study period (e.g. race or the chronic care mechanisms part of 
the conceptual framework). Other time-variant forms of heterogeneity (e.g. managerial 
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style, patient severity or patient access to healthcare services) will not be eliminated, 
which could result in biased inferences. 
The Heckman selection model was designed to solve the estimation challenges 
arising from truncation (J. Heckman, 1974). Heckman considers problems caused by 
selection as specification error or omitted variable bias that can be corrected using a two 
stage estimation method (J. J. Heckman, 1979). The first stage explicitly models the 
propensity of an individual observation to be in one of the categories defined by the 
endogenous selection variable (selection equation).  The estimated probabilities are then 
transformed and used in a second stage to help estimate consistent regression model 
coefficients of the outcome of interest (main equation) that take the magnitude of 
selection bias into account. The transformation of the predicted individual probabilities 
from the first stage selection equation is based on the first and second stage error 
correlations and the inverse Mills ratio. The inverse Mills ratio is the ratio of the 
probability density function over the cumulative distribution function of a distribution. It is 
used, along with the estimated selection coefficient, to compute the average selection 
effect. If selection exists but is disregarded, parameter estimates based just on the 
second stage will be inconsistent and biased (J. J. Heckman, 1979). 
For 𝑥! and 𝑧! vectors of exogenous variables influencing outcome 𝑦! and the selection 
process respectively, latent variable 𝑤!∗ and indicator variable 𝑤!, where  𝑤! = 1 𝑖𝑓 𝑤!∗ > 0, 𝑎𝑛𝑑 𝑤! = 0 𝑤!∗ ≤ 0, 
the equations characterizing the Heckman selection model are: 
 
Main equation: 𝑦! = 𝑥!𝛽 + 𝜀!   
where 𝑦! is observed only if 𝑤! = 1, and 
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Selection equation: 𝑤!∗ = 𝑧!𝛾 + 𝑢!, with 𝑃𝑟𝑜𝑏 𝑤! = 1 𝑧! = 𝜃(𝑧!𝛾) and 𝑃𝑟𝑜𝑏 𝑤! = 0 𝑧! = 1 − 𝜃(𝑧!𝛾) 
 𝜃(. ) is the standard normal cumulative distribution function. 𝜀! and 𝑢! are error terms of 
the two regression equations, which follow a bivariate normal with mean zero and 
covariance matrix 
𝜎! 𝑝𝑝 1 . 
An example of the Heckman selection model in the VHA context is provided by 
Shen et al. (Shen, Hendricks, Li, Gardner, & Kazis, 2005). In this work, the utilization of 
VHA outpatient care by veterans above 65 years of age (main equation) depends on 
their decision to seek care at the VHA or Medicare (selection equation).  Shen and 
colleagues predicted the probability of veterans using Medicare advantage (selection 
equation). The main factors explaining selection were socio-demographic 
characteristics, access/attachment to the VHA system, functional status and county level 
HMO supply (Shen, Hendricks, Li, Gardner, & Kazis, 2005). In another use of the 
selection model, Wong and colleagues modeled selection similarly to Shen and included 
it as part of a Heckman sample selection model to explore hospital readmissions among 
veterans enrolled in Medicare advantage (Wong et al., 2014).  
The treatment-effects model is an extension of Heckman sample selection. 
Unlike a Heckman sample selection model, the dependent variable is observed for all 
study subjects and an indicator variable (𝑤) capturing treatment status (ADA compliant 
or non-compliant in our case) is included in the main equation (Guo & Fraser, 2014).  
The equations of the treatment-effects model are expressed as follows: 
Main equation:  𝑦! = 𝑥!𝛽 + 𝑤!𝛿 + 𝜀! 
Selection (or treatment) equation: 𝑤! = 𝑧!𝛾 + 𝑢!, with 𝑃𝑟𝑜𝑏 𝑤! = 1 𝑧! = 𝜃(𝑧!𝛾) and 𝑃𝑟𝑜𝑏 𝑤! = 0 𝑧! = 1 − 𝜃(𝑧!𝛾) 
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Treatment-effects estimators are designed to solve a missing data problem to 
predict average treatment-effects (ATE) in a given population. ATE indicates the 
counterfactual average cost difference if all individuals in the sample received the 
treatment compared to the setting where none were treated. The missing-data problem 
arises because we only observe data on one of the two potential outcomes for each 
diabetic patient (compliant or non-compliant). 
Our treatment effects model was estimated using inverse probability weighting 
regression adjustment (IPWRA). IPWRA joins two estimators, regression adjustment 
(RA) and inverse-probability weighting (IPW). RA handles treatment assignment by 
fitting two separate models, one for those who were treated and another for those who 
were not, but it does not model treatment assignment. It uses averages of predicted 
outcomes to estimate the ATE. Figure 4.2 illustrates an RA example. The orange circles 
represent guideline non-compliant patients and blue triangles compliant ones. We 
observe how sicker patients (higher Nosos risk score) have higher outpatient costs 
regardless of their compliance status (Figure 4.2a). RA fits separate linear regression 
equations for compliant and non-compliant patients (Figure 4.2b) and estimates 
unobserved potential outcomes (expected costs for compliant patients if they were not 
compliant and costs for non-compliant patients if they were compliant, which are 
indicated as empty circles and triangles in the Figure 4.2b). Based on these 
counterfactuals, a treatment effect (ATE) is estimated for each patient (Figure 4.2c) and 
then averaged across the sample to obtain the ATE for the desired population. Figure 
4.2c shows how treatment effect is computed for two observations. The orange dot 
labeled Observed represents an observation of a non-compliant veteran. The point 
labeled 𝐸(𝑌!) on the orange regression line indicates the expected outpatient costs 
	69	
given patient’s Nosos scores and non-compliance. The point labeled 𝐸(𝑌!) on the blue 
line right above the orange dot is the expected outpatient costs for the same patient with 
the same Nosos scores if she had been compliant. The difference between the two 
expectations for the same individual represents the treatment effect for those who did 
not get the treatment. A parallel reasoning applies for the compliant individuals (blue 
triangle). 
Figure 4.2: Regression adjustment-Treatment-effects estimator 
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Figure 4.2a: Outpatient costs and Nosos risk 
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The IPW estimator explicitly models treatment assignment and uses weighted 
averages of the observed outcome to estimate the ATE. Under IPW, the weight for each 
observation is derived from the predicted probabilities of guideline compliance, which we 
denote by 𝑝!. In Figure 4.3 for example, relatively sicker non-compliant patients (the 
large orange circles) who will have a relatively low probability of being compliant, and 
relatively healthier compliant patients (the large blue triangles) who have a relatively low 
probability of being non-compliant, are assigned a larger weight. We will give extra 
weights to the experience of those sicker non-compliant patients and the healthier 
compliant patients that we do observe, in order to compensate for the sparseness of 
their number in the sample. Specifically, observations of compliant individuals are 
weighted by 1/𝑝! and non-compliant individuals by  !!!!! . The weights are larger when 
the probability of guideline compliance is small among compliant individuals and when it 
is large among non-compliant individuals (Robins & Rotnitzky, A, n.d.; D. B. Rubin, 
1974; Stata Corporation, 2015; Wooldridge, 2002).  
 
Figure 4.3: Inverse probability weighting-Treatment-effects estimator 
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Combining RA and IPW leads to a more efficient estimator. Specifically, IPWRA 
is a double-robust estimator providing consistent estimates even if either the selection or 
main equation are misspecified (but not both) (Becker & Ichino, 2002; Wooldridge, 
2002). It basically models the main equation within each treatment group (X=0 and X=1). 
Predicted costs (𝑌! 𝑎𝑛𝑑 𝑌! ) are obtained by treatment group given the covariates. 
Treatment is also modeled and a predicted probability (or propensity score) is obtained 
for each individual. These values are combined as indicated in Table 4.1 to compute the 
double-robust (DR) estimates of costs with and without treatment (Jonsson Funk et al., 
2011). 
Table 4.1: Double-robust estimates by treatment group 
 Treated Non-treated 
General form 𝑋𝑌!!!𝑃𝑆 − 𝑋 − 𝑃𝑆 𝑌!𝑃𝑆  (1 − 𝑋)𝑌!!!1 − 𝑃𝑆 + 𝑋 − 𝑃𝑆 𝑌!1 − 𝑃𝑆  
Abbreviations: PS, propensity score. PS=p(X=1|Z); X=treatment; 𝑌!!! and 𝑌!!! are the observed costs 
among treated (X=1) and non-treated (X=0) individuals respectively. 𝑌!=E(Y|X=0,Z)=predicted outcome 
given X=0;  𝑌!=E(Y|X=1,Z)=predicted outcome given X=1 
 
Notice that among treated individuals (X=1) the expression reduces to 𝑌!!!𝑃𝑆 − 1 − 𝑃𝑆 𝑌!𝑃𝑆  
Among non-treated individuals (X=0) the expression is 𝑌!!!1 − 𝑃𝑆 − 𝑃𝑆𝑌!1 − 𝑃𝑆 
As detailed in Funk and colleagues, these two expressions can be presented 
after some mathematical manipulations as an estimator for the mean costs if everybody 
had been treated or non-treated plus an augmentation term. The augmentation term 
results from multiplying the bias of the selection and main equations. If either bias equals 
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zero it eliminates the other. Therefore, if the selection or main equation are well-
specified, the augmentation term is zero and unbiased estimates is obtained (Jonsson 
Funk et al., 2011). 
 
Methods 
The treatment equation (the equivalent to the selection equation in the Heckman 
selection model) predicts the probability of ADA guideline compliance, accounting for 
patient, clinic and parent facility characteristics. Variable choice was guided by existing 
literature and our conceptual framework as detailed in chapter 2. We avoided the 
inclusion of regressors related to guideline compliance but irrelevant to costs, such as 
diabetes prevalence at the state level, as they may decrease precision (Brookhart et al., 
2006). The rest of the patient, clinic and facility covariates were included based on our 
conceptual framework (chapter 1) which results from a comprehensive literature review 
of the factors influencing quality of diabetes care. 
The treatment equation was specified as follows: 
log 𝑃 𝑄!" = 11 − 𝑃 𝑄!" = 1 =  𝛾𝑋!" + 𝜗𝐾!" + 𝛽𝐾!" + 𝛿𝐹!" + 𝛼𝐿 + 𝜆𝑌𝑒𝑎𝑟 + 𝜀!" 
where Q is quality of diabetes care (1=compliant with all tests and procedures, 0=not 
compliant) for patient i in year t, X includes patient characteristics (age, gender, marital 
status, enrollment priority, Elixhauser Index, mental health diagnosis, registry categories 
and insulin medication), K represents clinic characteristics (relational climate) and F is 
the set of parent facility variables (quit rate, funding available, number of beds, number 
of full time equivalent employees and teaching status). The model also includes clinic (L) 
and year (Y) fixed effects to account for the panel structure of our data (study years 
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2008–2012). 𝜀!" is the error term. 
The main equation predicts costs at the patient level and it is specified as a 
Generalized Linear Model (GLM) with the Gamma distribution and log link: 𝑙𝑛𝐸 𝐶𝑜𝑠𝑡!" = 𝛾𝑋!" + 𝜗𝑄!" + 𝛿𝐾!" + 𝛽𝐹!" + 𝛼𝐿 + 𝜆𝑌𝑒𝑎𝑟 + 𝜀!" 
for error term 𝜀!", and where C is costs of diabetic patient i in year t. X includes patient 
characteristics (age, gender, marital status, enrollment priority, chronically mentally ill, 
insulin medication and Nosos risk scores). Q is a dummy variable that indicates 
treatment compliance and captures quality of diabetes care (1=compliant with all tests 
and procedures, 0=not compliant). K includes clinic characteristics (urban/rural and 
relational climate) and F parent facility characteristics (teaching/non-teaching). The 
model also adds clinic (L) and year (Y) fixed effects to account for the panel structure of 
our data (study years 2008–2012). 
The treatment-effects model was estimated using Stata 14.1 stteffects. This 
procedure was originally designed to estimate treatment-effects in survival data. 
However, if a censoring variable is not specified, it can be used with non-survival data 
when the outcome variable follows a distribution of the exponential family (e.g. Normal, 
Poisson, Gamma). IPWRA includes a multistep logic but all equations are estimated by 
maximum likelihood initially and weighted-maximum likelihood simultaneously in one 
step leading to consistent point estimates and consistent variance-covariance of the 
estimator (Newey, 1984; Wooldridge, 2002).  
All estimators available in stteffects make two assumptions. First, the conditional 
independence assumption implies that treatment assignment is comparable to random 
assignment after conditioning on the covariates and, thus, the outcome does not depend 
on the treatment.  For example, assume that guideline compliant diabetic patients also 
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followed a healthier life style (including diet and exercise) than non-compliant ones. If life 
style is a relevant factor contributing to compliance but it was disregarded, guideline 
compliance and observed costs would not be conditionally independent. As a result, we 
could understate the influence of guideline compliance on outpatient costs as diabetic 
patients who were compliant (cost increasing) also had a healthier life style (cost 
saving). Consequently, the error term of the treatment equation and the main equation 
would not be independent.  
The conditional independence assumption was assessed based on the degree of 
balance across the model covariates. Balance checks are commonly used in treatment-
effects models to evaluate model specification.  Weighting methods can be understood 
as a tool to balance the covariates between treated and non-treated groups. The 
concept of balance checks relates to randomized controlled trials, where study subjects 
are equally distributed across the covariates. If the model is well specified, the weights 
resulting from the treatment-effects model should balance the regressors between the 
compliant and non-compliant groups. For all the covariates included into the treatment 
and main equation, we computed the standardized differences between the two 
treatment groups and the variance ratio. The regressors are considered balanced if the 
standardized differences are closer to zero and the variance ratio closer to 1 than the 
raw differences and ratio (Austin, 2009b; Normand et al., 2001). There is no clear 
consensus on how close to zero standardized differences should be to consider that the 
covariates are balanced between the two treatment groups. Some researchers suggest 
that a standardized difference lower than 0.1 (10%) denotes balanced covariates 
(Austin, 2009a). For the continuous variables (relational climate, quit rate and Nosos risk 
score) we evaluated the overlap in the density plots between the compliant and non-
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compliant groups after weighting. We also assessed the evolution across time of the 
study variables between compliant and non-compliant individuals. Similar trajectories 
between the two groups are a desirable property as it suggests that not only the two 
groups are comparable at a given point in time but also across time.   
Finally, we evaluated the model fit and specification of the treatment equation to 
understand if the double-robust property of the IPWRA held. Goodness of fit was 
evaluated with the c statistic, concordant c, and the Hosmer-Lemeshow c statistic. The 
c-statistic corresponds to the area under the Receiver Operating Characteristic curve 
(ROC), which displays the performance of a binary classifier system (compliance vs. 
non-compliance in our case) as the discrimination threshold changes. ROC maps the 
true positive rate (among those with treatment, the percentage correctly predicted) vs. 
the false positive rate (those predicted to be in the treatment group are observed a non-
treatment prediction). A relatively large c statistic implies a high true positive rate and 
low false positive rate. The minimum c statistic value is 0.5; the maximum is 1.0. Values 
between 0.7 and 0.8 show acceptable discrimination, values 0.8 to 0.9 indicate excellent 
discrimination and models above 0.9 demonstrate outstanding discrimination. The 
concordant c statistic indicates the probability that a randomly selected compliant patient 
will have a higher predicted probability of compliance compared to a randomly selected 
non-compliant patient. The Hosmer-Lemeshow c statistic evaluates whether the 
difference between observed and predicted values of the response variable are 
significant. The failure to reject the null hypothesis of no differences is a signal of good 
model calibration (Hosmer & Lemeshow, 2013). The power of a chi-square test to 
correctly reject a poorly fitting model increases with sample size. The Hosmer-
Lemeshow test may show some susceptibility to bias in very large samples. Due to the 
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large size of our study sample, we checked its performance in a simulation. We used 
100 random samples of 50,000 individuals each to compute the Hosmer-Lemeshow c 
statistic Test (Paul, Pennell, & Lemeshow, 2013b). We consider a p-value for this test 
above 0.05 to indicate no difference between the observed and expected counts of 
patients. The proportion of values above 0.05 was computed.  
We followed the same bootstrapping approach to conduct the Pregibon link test. 
The Pregibon link test estimates the treatment-effects equation with the linear predicted 
value and the squared linear predicted value as the only two explanatory variables 
(besides a constant). If the treatment equation is correctly specified, the coefficient of the 
squared linear predicted value should be non-significant. Otherwise, a significant 
coefficient signals misspecification, the omission of relevant variables or the incorrect 
choice of the link function (logit function in our case) (Pregibon, 1980) . 
Second, all estimators in stteffects operate under the sufficient overlap 
assumption. Conditional on the covariates, the range of the probability of guideline 
compliance (treatment) among compliant and non-compliant individual should overlap, 
which requires that each individual has a sufficiently positive probability of being 
assigned to each of compliance group. Besides having a common support, the two 
probability distributions should have a similar shape (Garrido et al., 2014). We plotted 
the probability distributions for guideline compliant and non-compliant diabetic patients 
and evaluated the existence of a common support and a similar distributions (Imbens, 
2000).   
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Sensitivity analyses 
First, we assessed how the results changed if the dummy variable indicating 
patients on insulin medication was excluded from the treatment equation. This variable is 
likely to be influenced by the treatment (guideline compliance) and may misleadingly 
bias the parameter estimates (Garrido et al., 2014). Second, instead of $3 million, two 
alternative thresholds defining top-coding of inpatients costs were tested including $1 
million and $114,955 (which corresponds to the 95%tile). Finally, 2012 inpatient cost 
data was excluded as a drop was observed in that year. Therefore, the inpatient cost 
treatment-effects model was only estimated using 2008–2011 data. 
 
Decomposition of the total influence of relational climate on costs into direct and indirect 
effects 
Relational climate influences quality and costs of diabetes care as indicated by 
the significant coefficients in the quality (chapter 2) and cost (chapter 3) models. But it 
also has an indirect influence on costs through quality. Relational climate increases the 
probability of guideline compliance and guideline compliance influences costs.  
The total influence of relational climate on costs is defined at the patient level. It 
can be decomposed into a direct and indirect influence by examining the difference in 
expected costs with a change in relational climate:  𝑇𝐸! = 𝐸 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 |𝑅𝐶 + 1 − 𝐸[𝐶𝑜𝑠𝑡𝑠(𝑄,𝑅𝐶)|𝑅𝐶] 𝑇𝐸! = 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 ∗ Pr 𝑄 𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 ∗ Pr (𝑄|𝑅𝐶)!!  
Where 𝑅𝐶 is relational climate, 𝑄 quality of diabetes care, 𝑄 = 1 indicates guideline 
compliance, while 𝑄 = 0 non-compliance. Pr stands for probability. 
By adding and subtracting 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 ∗ Pr 𝑄 𝑅𝐶! :  
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𝑇𝐸! = 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 ∗ Pr 𝑄 𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 ∗ Pr (𝑄|𝑅𝐶)!! + 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 ∗ Pr 𝑄 𝑅𝐶! − 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 ∗ Pr 𝑄 𝑅𝐶!  
By grouping terms: 
 
𝑇𝐸! = 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 ∗ Pr 𝑄 𝑅𝐶! + 𝐶𝑜𝑠𝑡𝑠 𝑄,𝑅𝐶 + 1 ∗ (Pr 𝑄 𝑅𝐶 + 1 − Pr 𝑄 𝑅𝐶 )!  
 𝐷𝐸! = 𝐶𝑜𝑠𝑡𝑠 𝑄 = 1,𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠 𝑄 = 1,𝑅𝐶 ∗ Pr 𝑄 = 1 𝑅𝐶+ 𝐶𝑜𝑠𝑡𝑠 (𝑄 = 0,𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠(𝑄 = 0,𝑅𝐶)) ∗ Pr (𝑄 = 0|𝑅𝐶) 𝐼𝐸! = 𝐶𝑜𝑠𝑡𝑠 𝑄 = 1,𝑅𝐶 + 1 ∗ Pr 𝑄 = 1 𝑅𝐶 + 1 − 𝑃𝑟 𝑄 = 1|𝑅𝐶 + 𝐶𝑜𝑠𝑡𝑠 𝑄 = 0,𝑅𝐶 + 1∗ Pr 𝑄 = 0 𝑅𝐶 + 1 − 𝑃𝑟 𝑄 = 0|𝑅𝐶  
Notice that the direct effect captures the change in expected costs due to a one-
unit increase in relational climate given the probability of guideline compliance (or non-
guideline compliance) at baseline (i.e. before the change in relational climate). The 
indirect effect indicates the change in the probability of guideline compliance (i.e. it 
includes the possibility that patients move from non-compliance to compliance) because 
of a one-unit change in relational climate multiplied by the expected cost differential at 
RC+1 between compliant and non-compliant individuals. In other words, the direct effect 
captures how relational climate influences costs given a certain compliance level, while 
the indirect effect represents the cost effects of changing the probability of being 
Direct	effect	(DE)	
Indirect	effect	(IE)	
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compliant because of an increase in relational climate. Figure 4.4 provides a visual 
representation of the direct and indirect effects of relational climate on costs. 
 
Figure 4.4: Direct and indirect effects of relational climate on costs 
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where  𝑌 ≡ 𝐶𝑜𝑠𝑡𝑠 𝑄 = 1,𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠 𝑄 = 1,𝑅𝐶  𝑋 ≡ 𝐶𝑜𝑠𝑡𝑠 𝑄 = 0,𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠(𝑄 = 0,𝑅𝐶)	𝑍 ≡ 𝐶𝑜𝑠𝑡𝑠 𝑄 = 1,𝑅𝐶 + 1 − 𝐶𝑜𝑠𝑡𝑠(𝑄 = 0,𝑅𝐶 + 1)		and	𝛼 ≡ Pr 𝑄 = 1 𝑅𝐶 + 1 − Pr (𝑄 = 1|𝑅𝐶)	
 
 
In Figure 4.4 the direct effect can be computed as Pr(Q=1|RC)*Y+(1-
Pr(Q=1|RC))*X and the indirect effect as αZ. Notice that αZ is equivalent to 𝐶𝑜𝑠𝑡𝑠 𝑄 =1,𝑅𝐶 + 1 ∗ Pr 𝑄 = 1 𝑅𝐶 + 1 − 𝑃𝑟 𝑄 = 1|𝑅𝐶 + 𝐶𝑜𝑠𝑡𝑠 𝑄 = 0,𝑅𝐶 + 1 ∗Pr 𝑄 = 0 𝑅𝐶 + 1 − 𝑃𝑟 𝑄 = 0|𝑅𝐶  after some algebraic manipulations2.  
The indirect influence of relational climate was added to the direct influence to 
obtain a final total estimate of the influence of relational climate on costs. These 
computations were conducted for outpatient, inpatient and total costs separately. In 
chapter 3, significant differences were found in the association between relational 
climate and the three cost items (outpatient, inpatient and total costs). We concluded 
that relational climate contributed to lower outpatient and total costs, but was a non-
significant predictor of inpatient costs. Under the modeling approach of a treatment-
effects model, we will assess the change in these results if selection bias is taken into 
account. More importantly, within each cost item, we will compute a total effect 
differentiating between an indirect and direct channel. 
 
																																																								
2 Notice that the definition of direct and indirect effects presented in this dissertation corresponds to a 
discrete change in relational climate. Alternately, it could be described based on an infinitesimal change in 
relational climate through derivatives 𝐸 𝐶𝑜𝑠𝑡𝑠 𝑅𝐶 = 𝐸 𝐶𝑜𝑠𝑡𝑠 𝑅𝐶,𝑄 Pr 𝑄 𝑅𝐶! ;  !"[!"#!"|!"]!"# = !" !"#$# !",!!"#! 𝑃 𝑄 𝑅𝐶 + 𝐸[𝐶𝑜𝑠𝑡𝑠|𝑅𝐶, 𝑞] !"(!|!")!"#!    The first term is the direct effect, defined 
as the probability-weighted change in costs. The second term is the indirect effect, defined as the cost-
weighted change in probabilities.		
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Results 
Table 4.2 presents the parameter estimates of the outpatient treatment-effects 
model. The results are stratified by compliance status. Overall, the parameter estimates 
have the same sign but the absolute magnitude is larger among the non-compliant 
group.  For example, non-compliant diabetic patients on insulin medication incurred 
outpatient costs 13.2% higher than non-dependent insulin patients. The outpatient cost 
difference by insulin dependence status was 6.3% among guideline compliant patients. 
Most importantly, relational climate became cost-neutral (a non-significant parameter 
estimate) among non-compliant patients, while cost-saving (a significant and negative 
parameter estimate) among compliant ones (MR=0.995, 95% CI 0.994–0.997). A one-
unit increase in relational climate reduced outpatient costs by 0.5%, which represents an 
average cost saving per patient in 2010 of $64.933.   
Table 4.3 compares compliant and non-compliant patients in terms of 
demographic and disease complexity and severity characteristics. Patients who were 
guideline compliant had more often the highest enrollment priority and were significantly 
sicker than non-guideline compliant veterans. Specifically, 68% of the compliant diabetic 
patients were on insulin medication compared to 56% in the non-compliant group. A 
higher percentage of patients in the compliant group had 2–4 diagnosed comorbidities 
(84% vs. 76%) and more than 4 comorbidities (8% vs. 6%). Also, the prevalence of a 
mental health diagnosis was higher among the compliant group (41% vs. 36%).  
 
  
																																																								
3 The expected cost for each patient was computed (A). (A) was multiplied by the MR and (B) was obtained. 
The difference between (A) and (B) was then averaged across the patients in our sample. 
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Table 4.2: Parameter estimates of the treatment-effects model for outpatient cost 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=65–74) 
  <65 -0.012 (-0.017, -0.007)*** 0.009 (0.005, 0.129)*** 
>=75 -0.111 (-0.118, -0.102)*** -0.101 (-0.107, -0.093)*** 
Gender 
(ref=female) 
  Male -0.136 (-0.148, -0.123)*** -0.112 (-0.122, -0.102)*** 
Marital status  
(ref=single) 
  Married 0.022 (0.017, 0.027)*** 0.004 (0.003, 0.06)* 
Enrollment priority              
(ref=1–3) 
  Groups 4–6 -0.061 (-0.067, -0.056)*** -0.061 (-0.065, -0.056)*** 
Groups 7–8 -0.173 (-0.181, -0.166)*** -0.155 (-0.161, -0.149)*** 
Chronically 
mentally ill (ref=no) 
  Yes 0.183 (0.161, 0.206)*** 0.099 (0.082, 0.116)*** 
Insulin (ref=no) 
  Yes 0.124 (0.119, 0.129)*** 0.062 (0.058, 0.065)***  
Log Nosos  0.781 (0.779, 0.783)*** 0.751 (0.748, 0.751)*** 
Relational climate -0.001 (-0.003, 0.001) -0.005 (-0.006, -0.003)*** 
Teaching status 
(ref=no) 
  Yes 0.102 (0.082, 0.123)*** 0.026 (0.007, 0.044)** 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean Ratio (MR) 
and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
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Table 4.3:  Comparison of patient characteristics between guideline compliant and non-
guideline compliant patients 
Variable Freq (%)† Compliant (%)            Non-compliant (%)                                T-test‡
Age        
p<0.001 (ref=<65) 472,389 (53.88) 51.58 55.52 
65–80 312,552 (35.65) 35.37 35.85 
>=80 91,826  (10.47) 13.05 8.63 
Gender  
   p=0.023 Male 847,437 (96.64) 96.71 96.61 
Marital status         p<0.001 
Married 471,131 (53.74) 42.35 57.65 
Enrollment priority               
  
p<0.001 Groups 1–3 458,555 (52.30) 50.43 53.64 
Groups 4–6 283,075 (32.29) 32.28 32.29 
Group 7–8 135,137 (15.41) 17.29 14.07 
Insulin (ref=no) 
   p<0.001 Yes 552,538 (63.02) 55.92 68.09 
 Nosos  2.79 (3.56) 2.61 2.93 p<0.001 
Relational 
climate 11.24 (1.27) 11.19 11.27 
p<0.001 
Elixhouser Index       
p<0.001 
0 or 1 105,756 (12.06) 17.87 7.91 
2 to 4 707,868 (80.74) 76.38 83.85 
More than 4 63,143    (7.21) 5.75 8.24 
Mental (ref=no) 
   
 
Yes 339,735 (38.75) 36.02 40.7 p<0.001 
 
Notes: † Percentage for categorical variables and mean (SD) for continuous variables. ‡ Two sample t-test 
for continuous variables, chi-square Rao-Scott for categorical ones. 
 
Unlike in chapter 3, relational climate becomes a significant predictor of inpatient 
costs when we account for endogeneity in quality through a treatment-effects model 
(Table 4.4).  
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Table 4.4: Parameter estimates of the treatment-effects model for inpatient cost 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=65–74)   
<65 0.053 (0.041,0.065)*** 0.067 (0.058,0.077)*** 
>=75 -0.018 (-0.033, -0.003)* -0.021 (-0.035,-0.007)** 
Gender (ref=female) 
 Male 0.087 (0.056, 0.117)*** 0.117 (0.094, 0.141)*** 
Marital status  (ref=single) 
 Married -0.047 (-0.058, -0.036)*** -0.038 (-0.047,-0.029)*** 
Enrollment priority                                             
(ref=1–3) 
 Groups 4–6 0.067 (0.055,0.078)*** 0.087 (0.078, 0.096)*** 
Group 7–8 0.134 (0.115, 0.153)*** 0.165 (0.151,0.179)*** 
Chronically mentally ill (ref=no)   
Yes 0.315 (0.286,0.344) 0.256 (0.231,0.282)*** 
Insulin (ref=no) 
 Yes 0.017 (0.006,0.029)** 0.045 (0.036,0.054)*** 
Log Nosos  1.021 (1.014, 1.028)*** 0.988 (0.983,0.994)*** 
Relational 
climate -0.014 (-0.018,-0.009)*** -0.017 (-0.021,-0.014)*** 
Teaching status (ref=no) 
 Yes -0.0003 (-0.041,0.039) -0.131 (-0.174,-0.088)*** 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean Ratio (MR) 
and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
 
A one unit increase in relational climate reduced mean expected inpatient costs 
by 1.39% (MR=0.986, 95% CI 0.982–0.991) and by 1.68% (MR=0.983, 95% CI 0.979–
0.986) among non-compliant and compliant patients respectively, which represents an 
average patient cost saving of and $468.72 and $569.16 in 2012. Notice how the 
magnitude of the inpatient cost-saving for a one-unit increase in relational climate is 
much larger than in the outpatient cost analyses. This is driven by both larger mean 
ratios and the larger intrinsic magnitude of inpatient costs compared to outpatient costs. 
Also, patients with a lower enrollment priority (higher group number) incurred on average 
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higher inpatient costs, which could be related to the lack of a regular source of care. 
Table 4.5 presents the parameter estimates of the total costs treatment-effects 
model. Relational climate is cost-saving in both groups. Specifically, a one unit increase 
in relational climate reduced total costs by 0.7% among the non-compliant group 
(MR=0.993, 95% CI 0.991–0.995) and by 1.1% among the compliant group (MR=0.989, 
95% CI 0.987–0.991), which translates into a patient cost saving in total costs in 2012 of 
$67.97 and $109.95 respectively. 
 
Table 4.5: Parameter estimates of the treatment-effects model for total costs 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 0.031 (0.026,0.037)*** 0.049 (0.045, 0.053)*** 
>=75 -0.034 (-0.042, -0.026)*** -0.039 (-0.046, -0.032)*** 
Gender (ref=female) 
 Male -0.031 (-0.043, -0.016)*** -0.022 (-0.033,-0.121)*** 
Marital status  (ref=single)   
Married -0.007 (-0.012, -0.002)** 0.0008 (-0.003,0.005) 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 0.149 (0.009, 0.021) *** 0.019 (0.014, 0.023)*** 
Group 7-8 -0.055 (-0.063, -0.048)*** -0.031 (-0.037,-0.025)*** 
Chronically mentally ill  
(ref=no)   
Yes 0.099 (0.079,0.119)*** 0.073 (0.056,0.091)*** 
Insulin (ref=no) 
 Yes 0.085 (0.079,0.089)*** 0.053 (0.049,0.057)*** 
Log Nosos  1.141 (1.131,1.143)*** 1.059 (1.057, 1.061)*** 
Relational climate -0.007 (-0.009, -0.005)*** -0.011 (-0.013,-0.009)*** 
Teaching status 
(ref=no) 0.086 (0.065, 0.107)*** -0.008 (-0.028,0.012) 
Yes     
Urban/Rural 
(ref=rural) -0.048 (-0.059, -0.037)*** -0.032 (-0.042,-0.023)*** 
Notes: a The model also adjusts for the wage index. †Log Mean Ratio (MR) and 95% Confidence 
Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
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Tables C1-C3 on the appendix present the parameter estimates of the selection 
equation describing guideline compliance for each of the three treatment-effects models. 
Results are comparable to chapter 2. 
Table 4.6 provides a summary of the parameter estimates of relational climate on 
costs under the treatment-effects model and ignoring selection (chapter 3). Notice that 
the magnitude of the negative association is larger in the treatment-effects model, 
particularly for the inpatient cost model. 
Table 4.6: Relational climate parameter estimates, chapter 3 vs. chapter 4 
Cost item 
  MR (95% CI) 
2012 Cost 
change per 
patient  of 1 
RC unit‡ 
Outpatient 
Ignoring 
selection† 
 
0.996                               
(0.994,0.997) 
-$45.19 
Treatment-
effects 
Q=1 0.995                            
(0.994,0.997) 
-$64.93  
Q=0 non-significant cost-neutral 
Inpatient 
Ignoring  
selection‡ 
non-
significant 
cost-neutral 
Treatment-
effects 
Q=1 0.986 (0.982,0.991) -$569.16 
Q=0 0.983 (0.979,0.986) -$468.72 
Total costs 
Ignoring  
selection* 
0.998                
(0.996,0.999) -$47.47 
Treatment-
effects 
Q=1 0.989                               (0.987,0.991) -$109.95 
Q=0 0.993                     (0.991,0.995) -$67.97 
Notes: †See page 50 for the full outpatient cost model results. ‡ See page 52 for the full inpatient cost model 
results. *See page 53 for the full total cost model results. ‡ The expected cost for each patient was 
computed (A). (A) was multiplied by the MR and (B) was obtained. The difference between (A) and (B) was 
then averaged across the patients in our sample. 
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Model assessment 
The balance checks for the three treatment-effects models (outpatient, inpatient 
and total cost) indicate that the models are well-specified. Tables C4-C6 present the 
differences (standardized and as a ratio) between the compliant and non-compliant 
patients across the model regressors. The weighted standardized differences are closer 
to 0 than the raw standardized differences and the weighted variance ratios are closer to 
1 than the raw variance ratios. All weighted standardized differences are lower than 0.1. 
Therefore, the balance of covariates between the compliant and non-compliant groups is 
satisfying. Also, the study covariates followed a similar evolution across time (Figure 
C1). Figure 4.4 presents the distribution of the estimated probability of compliance for 
compliant and non-compliant diabetic patients. The densities for the two groups seem to 
have the same support and a similar shape, thus, the sufficient overlap assumption 
appears to be fulfilled.  
Figure 4.4: Distribution of propensity scores by treatment group
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The c statistic of the treatment equation was 0.68, which indicates that the model 
is able to discriminate well between those diabetic patients who were guideline 
compliant and those who were not.  The ratios of observed over expected observations 
across deciles of the probability of guideline compliance are very close to 1, suggesting 
good model fit (Table C7). Similarly, the bootstrapping results of the Hosmer-Lemeshow 
test indicate that we fail to reject the null hypothesis of significant differences between 
observed and predicted values of the response variable (treatment compliance). Most p-
values (86%) corresponding to the chi-square test are larger than 0.05 (Figure C2).  
Finally, the results of the Pregibon specification test suggest the treatment equation was 
well-specified as the parameter estimate of the squared of the predicted values was 
overall non-significant (88% of the estimates) (Figure C3). Therefore, the double-robust 
property of the IPWRA estimator appears to hold. 
 
Sensitivity analyses 
The relational climate parameter estimates in both the main equation and the 
treatment equation remained quite stable across the different sensitivity analyses 
(Tables 4.7-4.9, full results Tables C8-C10).  
Table 4.7 presents the parameter estimates for relational climate across the 
outpatient, inpatient and total cost models when insulin was dropped from the treatment 
equation. Relational climate became a statistically significant predictor of outpatient 
costs across non-compliant individuals (MR=0.997, 95% CI: 0.995,-0.999), while it was 
found non-significant among this compliance group in the main results (Table 4.7).  
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Table 4.7: Sensitivity analysis 1 (summary): Relational climate parameter estimates if 
insulin is dropped from the treatment equation 
  
Outpatient Costs  Inpatient Costs  Total Costs  
Cost 
model 
Non-
compliant 
-0.003                                              
(-0.004, -0.001)*** 
-0.013                                  
(-0.018, -0.009)*** 
-0.007                                         
(-0.009, -0.005)*** 
Compliant -0.006                                               (-0.007, -0.004)*** 
-0.018                                           
(-0.021, -0.014)*** 
-0.011                             
(-0.013, -0.009)*** 
Quality model 0.041                                 (0.038, 0.045)*** 
0.035                            
(0.029, 0.041)*** 
0.042                       
(0.0381, 0.045)*** 
Note: Main results: Log mean ratio for the outpatient cost model among non-compliant individuals:  
-0.0001 (95% CI: -0.003, 0.001); for compliant individuals: -0.005 (-0.007,-0.004). Log mean ratio 
for the inpatient cost model among non-compliant individuals: -0.014 (-0.018,-0.009); for compliant 
individuals: -0.017 (-0.021,-0.014). Log mean ratio for the total cost model among non-compliant 
individuals: -0.007(-0.009,-0.005); for compliant individuals -0.011(-0.012,-0.009). Log mean ratio 
for the quality model part of the treatment-effects outpatient cost model:  0.043 (0.039-0.472). Log 
mean ratio for the quality model part of the treatment-effects inpatient cost model: 0.034 (0.028-
0.041). Log mean ratio for the quality model part of the treatment-effects total cost model: 0.042 
(0.038-0.046). 
 
The inpatient cost results were not sensitive to the $1m or $114,955 top coding 
thresholds (Table 4.8). Therefore, we can conclude that alternative thresholds (instead 
of $3 million) lead to comparable results. 
 
Table 4.8: Sensitivity analysis 2 (summary): Relational climate parameter estimates with 
alternative top-coding thresholds for inpatient costs 
  
Top-coding at $1m Top-coding at $114,955 
Cost 
model 
Non-
compliant 
-0.013                                       
(-0.017, -0.009)*** 
-0.011                                          
(-0.016, -0.007)*** 
Compliant 
-0.017                                              
(-0.021, -0.014)*** 
-0.013                                                  
(-0.017, -0.011)*** 
Quality model 0.034                          (0.028, 0.041)*** 
0.035                                        
(0.028, 0.041)*** 
Note: Main results: Log mean ratio for the inpatient cost model among non-compliant individuals: -
0.014 (-0.018, -0.009); for compliant individuals: -0.017 (-0.021, -0.014). Log mean ratio for the 
quality model part of the treatment-effects inpatient cost model: 0.034 (0.028-0.041) 
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Finally, when 2012 inpatient data was dropped, the relational climate parameter 
estimate remained positive and statistically significant, but it almost doubled in 
magnitude (MR=1.065, 95% CI: 1.057, 1.073) (Table 4.9). 
 
Table 4.9: Sensitivity analysis 3 (summary): Relational climate parameter estimates if 
2012 inpatient cost data is dropped 
Cost 
model 
Non-
compliant 
-0.015                                              
(-0.021, -0.011)*** 
Compliant 
-0.021                                                  
(-0.024, -0.016)*** 
Quality model 0.063                                        (0.056, 0.071)*** 
Note: Main results: Log mean ratio for the inpatient cost model among non-compliant individuals: -
0.014 (-0.018,-0.009); for compliant individuals: -0.017 (-0.021,-0.014). Log mean ratio for the 
quality model part of the treatment-effects inpatient cost model: 0.034 (0.028-0.041) 
 
The direct, indirect and total influence of relational climate on costs 
The association between relational climate and costs in 2012 is presented in 
Table 4.10 differentiating among direct, indirect and total influence by cost category 
(outpatient, inpatient and total costs). Both the average and total computations are 
included. The indirect influence of relational climate on costs is positive (cost increasing) 
for outpatient and total costs, but negative (cost saving) for inpatient costs. As we found 
in chapter 3, guideline compliance increases outpatient and total costs but reduces 
inpatients costs. The total influence of a one unit increase in relational climate on costs 
is negative (cost-saving) for inpatient and total costs, while cost increasing for outpatient 
costs.  
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Table 4.10: The association between relational climate and outpatient, inpatient and total 
costs based on the treatment-effects models 
	 Average effect† Total effect 	 Direct Indirect Total Direct Indirect Total Outpatient                 
Costs 
-$40.67 $103.11  $62.44 -$7,325,592 $18,600,000 $11,274,408 
Inpatient                     
Costs 
-$488.51 -$21.34    -$509.09 -$32,100,00 -$1,449,694 -$33,549,694 
Total                                    
Costs  -$221.62 $7.62  -$214 -$40,200,000 $1,383,775 -$38,816,225 
Note: † Notice that the computations of the direct and indirect effects based on the equations presented on 
page 77 are at the patient level. We can then compute an average (average effect) or sum across all 
patients in 2012 (total effect).  
 
Specifically, a one unit increase in relational climate is associated with an increase in 
outpatient costs of  $11 million and a reduction in inpatient and total costs of $33 million  
and $38 million respectively. Overall, these results suggest that relational climate is cost-
saving (based on the total cost results) even when its indirect relationship with costs 
through quality is accounted for. 
 
Discussion and Conclusions 
Relational climate contributes to lower inpatient and total costs. We decomposed 
the total influence of relational climate on costs into a direct and an indirect effect. The 
direct effect was negative (cost-saving) across outpatient, inpatient and total costs. The 
indirect effect was cost-saving for inpatient costs, but cost increasing for outpatient and 
total costs. We conclude that improving relational climate in primary care is related with 
cost-savings for diabetes care even after accounting for the influence of relational 
climate on costs through quality. 
The decomposition of the influence of relational climate on costs into direct and 
indirect effect required accounting for the endogeneity in quality of diabetes care (ADA 
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guideline compliance). Three separate treatment-effects models for outpatient, inpatient 
and total costs were fit. The estimation results were presented by treatment compliance. 
Considerable differences in parameter estimates (including the ones for relational 
climate) were observed between compliant and non-compliant patients. An increase in 
one unit in relational climate reduced mean expected outpatient costs by $65 per patient, 
mean expected inpatient costs by $569 per patient and mean expected total costs by 
$110 per compliant patient. Among non-compliant patients these quantities were $0 
(non-significant), $469 and $68 respectively. Notice that these effects are overall modest 
in magnitude. However, once aggregated from the individual patient to the whole study 
sample, the cost saving potential of relational climate becomes non-trivial. 
Chapters 3 and 4 lead to the same conclusion: relational climate is related to 
lower costs. However, some variation in the parameter estimates of relational climate 
was observed between the two chapters. Overall, the magnitude was larger in the 
treatment-effects models. The results of outpatient cost treatment-effects model indicate 
that relational climate reduces outpatient costs only among compliant veterans (it is cost-
neutral among non-compliant subjects). Non-compliant patients may be less engaged in 
their care, which could be in part due to lower disease severity and complexity. Our 
results suggest that compliant veterans were on average sicker than non-compliant 
ones. Also, the parameter estimate of relational climate part of the inpatient treatment-
effects cost model became statistically significant and negative (cost-saving) instead of 
non-significant (cost-neutral in chapter 3). Differences in the parameter estimates 
between chapters 3 and 4  may stem from self-selection bias (uncontrolled confounders) 
or measurement error in quality part of the cost models in chapter 3. As a result, quality 
of diabetes care may be related to the error term (endogeneity), which may lead to 
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biased parameter estimates. Some examples of uncontrolled confounders include 
leadership style, communication among providers, employee productivity, absenteeism 
or patient waiting time to book an appointment. Measurement error in quality refers to 
differences between the number of tests and procedures that the patient actually 
received and the information that appears in the VHA administrative dataset used for this 
study. Some tests and procedures may be conducted but not recorded, or patients may 
use their Medicare coverage.  
In chapter 3, the specification of the cost equation was assessed with the 
modified Hosmer-Lemeshow Test. The results of the test indicated some difficulties to 
accurately predicting the upper end of the cost distribution, suggesting model 
misspecification. Some variables that were not included in the model and that may 
influence costs are patient diabetes education, patient life-style, patient functional status, 
provider type, waiting time to get an appointment, continuity of care (vs. fragmentation), 
among others. In chapter 4, the cost models were estimated simultaneously with the 
quality (treatment) equation within the framework of a treatment-effects model using the 
IPWRA estimator. The double robust property of this estimator ensures consistent 
parameter estimates as long as one of the two equations is correctly specified. 
Goodness of fit statistics (c-statistic and the Hosmer-Lemeshow test) and the Pregibon 
Link Test confirmed the correct specification of the quality equation. Therefore, the 
parameter estimates parts of chapter 4 are consistent as well as the variance-covariance 
matrix of the estimator. Notice that other estimators besides IPWRA have the doubly-
robust property in the context of treatment-effects model. Regression estimation with 
residual bias correction and regression estimation with propensity-based covariance are 
two examples (Kang & Schafer, 2007). Existing literature recommends selecting the 
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estimation method based on its ability to reduce covariate imbalance across treated and 
untreated groups. In our case, IPWRA achieved an acceptable balanced sample 
between the two groups.  
Both chapters 3 and 4 highlight the complex relationship between quality and 
costs of diabetes care. Chapter 3 concluded that guideline compliance increased 
outpatient costs and total costs, but reduced inpatient costs. The provision of ADA tests 
and procedures is expensive by itself. Also, compliant patients may be more engaged in 
their healthcare and use health services more often than non-compliant ones. The 
inpatient cost-saving potential of treatment compliance highlights the importance of the 
ADA recommended tests and procedures to avoid diabetes complications and related 
hospitalizations. In chapter 4, the costs models were stratified by compliance status as 
part of the treatment-effects framework. These analyses revealed that the outpatient 
costs savings of relational climate originated from compliant individuals only, while for 
inpatient and total costs from both groups. The treatment-effects model with the IPWRA 
estimator is an innovative solution to account for the endogeneity in quality of care when 
predicting costs. If the assumptions underlying this modeling approach are fulfilled, the 
IPWRA estimator produces consistent parameter estimates, which may help to 
understand the sign and magnitude of the association between quality and costs of care. 
Existing research examining the relationship between costs and quality is mixed.  
Hussey and colleagues conducted a systematic review of studies published between 
1990 and 2012. Most of the studies using instrumental variables to address confounding 
by patient characteristics found a positive relationship between quality and total costs 
(Hussey, Wertheimer, & Mehrotra, 2013). Abraham and colleagues concluded based on 
a commercially-insured panel (2006-2009) of diabetic patients that provider-initiated 
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processes of care (e.g. HbA1c test, LDL-C screening, nephropathy or insulin medication) 
were cost increasing (Abraham, Crespin, McCullough, & Christianson, 2014). Future 
research exploring the relationship between costs and quality of chronic conditions 
should identify patient, provider and system level factors that contribute to quality of care 
and assess how these variables may interact with costs.  
Some study limitations should be acknowledged. First, we partially modeled the 
selection of patients into different levels of testing. A more comprehensive approach 
would first apply a Heckman selection model to predict the decision of using VHA or 
Medicare services to obtain diabetes care. Then treatment compliance and costs among 
VHA users would be assessed in a treatment-effects model. We did not have access to 
Medicare data and, thus, our results disregard potential care received by dual-eligible 
patients outside of the VHA system. Future studies should explore how to combine 
within a unifying estimation framework selection and treatment-effects models. Second, 
quality of diabetes care was measured through guideline compliance (an all-or-none 
quality indicator). It allowed us to assess how an increase in relational climate changed 
the probability of guideline compliance but not how it affected the stepwise process to 
guideline compliance (e.g. from 3 to 4 tests). We attempted to use the number of tests in 
the treatment equation estimated as an adjacent-categories logit. However, to our 
knowledge, Stata did not accommodate an adjacent-categories logit to estimate the 
treatment equation and a GLM Gamma distribution with the log link to estimate the main 
equation. We then explored the modeling possibilities under the mtreatreg command in 
Stata. However, this procedure assumes a multinomial distribution for the response 
variable of the treatment equation, which implies that there is no ordering among the 
different categories. This framework did not seem appropriate to model the number of 
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tests and procedures. We then decided to use the all-or-none indicator. Also, as 
discussed in chapter 2, the importance of each test (or combinations of tests) is patient-
dependent. Ideally, combinations of tests could be ordered by patient health benefit and 
costs. We could then evaluate how relational climate facilitates the most effective 
combinations of testing. However, our analyses are a valuable first step to understand 
how organizational variables influence costs not only directly but also through quality of 
care. Our results provide preliminary evidence of a highly significant and moderate in 
magnitude cost saving influence of relational climate on costs of diabetes care.  
In conclusion, this chapter confirms that a strong relational climate may be a 
strategic asset to healthcare organizations. Relational climate contributes to higher 
quality of diabetes care and lower costs. It may facilitate the implementation of the 
patient-centered medical home by optimizing human capital resources and fostering 
collaborative team dynamics. The three studies part of this dissertation lead to the 
conclusion that relational climate in primary care contributes to better observed quality 
and lower observed costs of diabetes care. 
  
	97	
CHAPTER 5: CONCLUSIONS 	
As we re-design our healthcare system to achieve the triple aim of better health, 
better care experience and lower costs, it is critical to understand the influence of 
organizational variables underlying the structure of the healthcare delivery system on 
outcomes. Integrative teams part of patient-centered medical homes increase the 
dependence among providers and require functional interpersonal relationships to 
ensure its success. Relational climate is a measure of the work environment that may be 
particularly relevant in this context. This dissertation provides convincing evidence that 
relational climate contributes to guideline compliance of diabetes care and lower costs. If 
in 2012 all clinics had a relational climate score of at least 14, 12,000 more diabetic 
veterans would have been guideline compliant. Also, a one unit increase in relational 
climate across all VHA clinics would have reduced total costs of diabetic patients by 38 
million. More than 50% of the clinics had a relational climate score lower than 11.2 in 
2012, which appears to signal a need to enhance interpersonal interactions.   
Relational climate can be improved. Since 2005, the VHA has been 
implementing the Civility, Respect, and Engagement in the Workforce (CREW) 
intervention. CREW is aimed at improving the work environment by fostering civil and 
respectful interactions. It is an optional workgroup-level initiative based on the premise 
that employee behavior is driven by the work environment. Currently about 50 out of 130 
VHA facilities have adopted CREW. The problematic areas of the work environment are 
identified based on the civility survey. The survey includes the 3 items we used to 
measure relational climate and five more questions on workgroup respect, coworker 
personal interest, coworker reliability, anti-discrimination and supervisor diversity 
acceptance. Some of the educational tools offered by CREW include possible questions 
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to guide discussions of pre-survey and follow-up assessments, vignettes portraying 
situations for group problem solving, examples of successful group experiences, rating 
the work environment every day and discussing potential challenges the next day, or 
filling in sentences such as “I could be more productive at my job if…”.  These resources 
are shaped by users and tailored to the local needs of the organization according to its 
organizational culture. The CREW intervention is assessed based on the comparison of 
the pre- and post- survey results. It has been related to lower employee burnout, lower 
intention to leave and higher patient satisfaction (Osatuke, Moore, Ward, Dyrenforth, & 
Belton, 2009; Veterans Affairs, 2010).  
Our cost-saving computations of relational climate could not account for the 
actual cost of increasing relational climate by one unit. The CREW initiative provides a 
useful framework of reference to understand how relational climate can be improved. 
However, the specific cost information related to a one unit increase in relational climate 
is unknown. VHA facilities do not have to pay to implement CREW. The only cost of 
adopting this intervention is the time off-work of the participating employees. Between 10 
and 25 employees attend the CREW sessions, which last between 2 to 2.5 days. More 
granular information is needed to provide precise estimates of the total cost of improving 
the work environment. Similar interventions require a multidimensional evaluation of its 
effectiveness including workgroup performance indicators, patient outcomes, but also 
budget implications.  
Chapter 3 illustrates the methodological challenges of modeling healthcare costs. 
For outpatient, inpatient and total costs, a GLM model with the Gamma distribution and 
the log-link performed better than an OLS logged model with the Duan’s adjustor for 
retransformation. However, as Tables 3.5 and 3.6 indicate, our modeling approach led to 
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a larger predictive error in the inpatient cost model compared to the total and outpatient 
costs models. We measured relational climate in primary care (outpatient), so the model 
specification was less focused on capturing inpatient care dynamics. The three cost 
models faced some difficulties to predict costs accurately at the upper end of its 
distribution. The modified Hosmer-Lemeshow test indicated misspecification in the cost 
equations. The three cost models were specified identically. Differences were observed 
in the influence of relational climate on cost across the outpatient, inpatient and total cost 
models. Future research should identify explanatory variables unique to the outpatient or 
inpatient setting to refine cost model specifications. Some candidates include the 
existence of a regular source of care, waiting time to get an appointment with the 
primary care provider, reason of hospitalization, or number of hospitalizations in a given 
year.  
Subsequent work should assess alternative cost estimation techniques. Quantile 
regression is a promising yet mostly unexplored approach to cost modeling in health 
services research. OLS regression models the relationship between the conditional 
mean of a dependent variable and the explanatory variables. In contrast, quantile 
regression focuses on explaining the quintiles of the dependent variable. Therefore, 
quantile regression is particularly relevant as the upper quintiles of the cost distribution 
are of critical interest from a health services research perspective to device strategies to 
control costs. Quantile regression estimates are more robust against outliers in the 
response variable than least squares estimation (Angrist & Pischke, 2008; Chen & Wei, 
2005).   	 This dissertation also highlights the multidimensional nature of quality of care and 
the importance of measuring it through more than one indicator. Quality of diabetes care 
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was evaluated with several indicators capturing both processes and intermediate 
outcomes of diabetes care. An all-or-none indicator of ADA guideline compliance and a 
count variable indicating the number of tests and procedures were built. Intermediate 
outcomes included the actual levels of LDL-C, HbA1c and blood pressure. We found that 
relational climate was associated with process-based indicators positively, but it was a 
non-significant predictor of intermediate outcomes. The compound nature of quality of 
care requires a comprehensive measurement approach to identify the specific quality 
aspects that organizational variables have the potential to influence. Future research 
could also test the mechanism through which we hypothesize that relational climate may 
contribute to higher quality and lower costs of diabetes care. A strong relational climate 
may increase the motivation and effort exerted by providers including a higher 
willingness to work together and jointly improve patient care. Structural equation 
modeling could serve as a useful estimation model to test these relationships. 
As we move towards personalized medicine, identifying one or a subset of 
diabetes-related tests that are essential based on patient characteristics could help to 
prioritize care and inform a stepwise approach toward guideline compliance. A hierarchy 
of tests and procedures by relevance to clinical outcomes could be established. Based 
on this information, organizational variables or, more generally, characteristics of the 
healthcare delivery system that contribute to the most cost-effective combinations of 
tests and procedures could be explored.  This personalized approach to guideline 
compliance could contribute to lower costs of diabetes care without compromising 
quality of care.  
 Another future direction of this work is in measuring relational climate in clinical 
settings other than primary care, such as inpatient care or the emergency room. 
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Inpatient costs account for most of diabetes total costs. Thus, exploring how the 
inpatient work environment influences patient outcomes is needed. A strong relational 
climate may be particularly an asset in the emergency room. Time constraints make 
orchestrated task assignment along with fluent communication particularly essential to 
organizational performance and patient outcomes (Aminzadeh & Dalziel, 2002).  Future 
research also should explore the influence of relational climate on costs and quality of 
care in other conditions that require care team-based care provision such as cancer, 
heart disease or arthritis.  
 In an era of patient centered care, we need to identify relationships between the 
functioning of the healthcare system and patient outcomes to inform interventions aimed 
at improving quality and reducing costs of care. This is particularly relevant to chronic 
conditions such as diabetes given the alarming projections of its prevalence in the 
coming 10 years. This dissertation brings together organizational behavior, health 
economics and patient outcomes research to unveil a rather unexplored area: how the 
interpersonal work environment, which is amenable to change, influences healthcare 
quality and costs. Based on longitudinal data from the VHA, we conclude that improving 
relational climate is a cost-effective intervention for healthcare organizations.  
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  APPENDIX A 
Table A1: Items from the AES used to measure relational climate 
1) A spirit of cooperation and teamwork exists in my groups 
2) Disputes or conflicts are resolved fairly in my work group 
3) Differences among individuals are respected and valued in my work group 	
Figure A1: Sample size evolution to build relational climate based on the AES 	
		 					 		
	
	
	
	
 2008 2009 2010 2011 2012 
Respondents 164502 169242 208642 198851 195340 
Workgroups 10632 11169 12426 13125 13381 
Stations 133 192 261 273 276 
            
Respondents 32077 34629 37193 38988 36195 
Workgroups 2092 2206 2284 2499 2505 
Stations 130 138 138 132 131 
            
Respondents 6926 6970 7999 8325 8401 
Workgroups 1123 1193 1238 1343 1396 
Stations 129 129 129 130 130 
      
      
Respondents 5744 5681 6712 6998 7879 
Workgroups 935 995 1042 1147 1289 
Stations 100 105 104 113 111 
            
Respondents 5646 5601 6627 6881 7120 
Workgroups 924 990 1030 1140 1199 
Stations 100 105 104 113 111 
Respondents 4566 4487 5435 5561 5781 
Workgroups 550 594 617 674 724 
Stations 99 103 102 110 111 
Respondents 3531 3571 4335 4426 4470 
Workgroups 423 472 489 529 556 
Stations 98 100 101 108 108 
·Station number 
missing 
·Workgroups without 
members working in 
primary care 
Non-direct providers 
Stations with CBOCs 
but not detailed in the 
AES 
 
2 or 3 elements of 
relational climate 
missing 
 
Workgroups in 
hospital-based clinics 
with less than 50% of 
their members in 
primary care (on 
average across 2008-
2012) 
 
Workgroup names 
unrelated to primary 
care 
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Table A2: Occupational categories of interest from the AES 
Clinical Nurse Specialist Physician - Medicine including all sub-specialists 
Educator/Learning Officer (for example 
Nurse) Physician - Primary Care 
LPN Physician - Psychiatrist 
Nurse Practitioners Physician - Surgeon including all sub-specialists 
Nursing Assistant Physician Assistant 
Optometrist Podiatrist 
Other certified or licensed hands-on direct Psychologist 
Other non-licensed hands-on direct patient RN - Level I 
Pharmacist RN - Level II 
Pharmacy Technician RN - Level III 
Physical Medicine Therapist RN - Level IV 
Physician - All other physicians RN - Level V 
Physician – Anesthesiologist Social Worker 	
 
Table A3: Conditions included in the Elixhauser Index 
Congestive heart failure Lymphoma  
Cardiac arrhythmias Metastatic cancer 
Valvular disease Solid tumor without metastasis 
Pulmonary circulation 
disorders Rheumatoid arthritis 
Peripheral vascular 
disorders Coagulopathy 
Hypertension Obesity 
Paralysis Weight loss 
Fluid and electrolyte 
disorders Blood loss anemia 
Chronic pulmonary 
disease Deficiency anemias 
Diabetes uncomplicated Renal failure 
Diabetes complicated Peptic ulcer 
Liver disease Hyperthyroidism 
AIDS Renal failure 
Alcohol abuse Liver disease 
Psychoses Depression 
Source: Elixhauser, A., Steiner, C., Harris, D. R. & Coffey, R. M. Comorbidity Measures for Use with 
Administrative Data. Medical Care 36, (1998). 
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Table A4: Conditions part of the VA registry categories 
Spinal cord injury Alcohol dementia 
Chronically mentally ill Stroke 
Blind rehab Hepatitis C 
Post-traumatic Stress 
Disorder (PTSD) 
Long-term care patient 
Domiciliary patient Home health 
AIDS Transplant 
End stage renal disease 	
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Table A5: Patient, clinic and facility sample characteristics 2008-2012 
 
 
2008 2009 2010 2011 2012 
Patient 296,183 321,272 327,805 325,664 297,256 
Age 67.42 (11.31) 66.40 (11.23) 65.51 (11.17) 64.59 (11.09) 63.82 (11.20) 
Gender (Male) 
96.60                    
(96.54-96.67) 
96.58                    
(96.52-96.65) 
96.44                   
(96.37-96.50) 
96.25                   
(96.19-96.32) 
96.07  
(96.01-96.14) 
Marital Status 
     Single; Married; Separated, Divorced or 
Widowed; Unknown (Married) 
35.65                 
(35.47-35.82) 
35.42 
 (35.25-35.58) 
35.55                   
(35.38-35.71) 
36.01                   
(35.95-36.15) 
35.95  
(35.80-36.05) 
Priority status 
     
Group 1-Group 8 (Group 1) 
35.02                  
(34.85-35.20) 
35.33                    
(35.16-35.49) 
35.36                   
(35.20-35.53) 
35.82                  
(35.66-35.99) 
35.7 
 (35.51-35.87) 
Elixhauser Index (0,1,2-4, +4)  
     
2-4 (both included) 
80.89                   
(80.75-81.03) 
80.84                  
(80.70-80.97) 
80.69                     
(80.55-80.82) 
80.49                     
(80.35-80.62) 
80.02 
 (79.87-80.16) 
Mental Health Diagnosis (Yes) 
36.24                     
(36.07-36.41) 
37.06                  
(36.90-37.23) 
37.94                    
(37.78-38.11) 
38.95                   
(38.78-39.11) 
39.98  
(39.81-40.16) 
Insulin (Yes) 
62.06                 
(61.89-62.24) 
60.65                  
(60.48-60.82) 
59.14                  
(58.97-59.31) 
58.54                 
(58.37-58.71) 
57.22 
(57.01-57.40) 
% All tests and procedures (Yes) 
51.62                  
(51-44-51.80) 
56.55                   
(56.38-56.72) 
56.78                      
(56.61-56.95) 
55.89                    
(55.70-55.99) 
55.54 
 (55.36-55.72) 
Five or four vs. fewer than 4 (5 or 4) 
82.27                    
(82.14-82.41) 
84.61                  
(84.49-84.74) 
84.85                  
(84.73-84.97) 
84.70                   
(84.10-84.84) 
84.53 
(84.40-84.66) 
LDL-C 92.49 (34.88) 91.89 (34.78) 91.88 (34.85) 89.97 (34.83) 90.29 (35.28) 
Blood Pressure 
     Systolic 133.29 (19.74) 133.38 (19.55) 133.28 (19.38) 133.33 (19.47) 133.66 (19.68) 
Diastolic 74.37 (12.53) 74.70 (12.54) 74.85 (12.46) 75.06 (12.45) 75.24 (12.50) 
HbA1c 7.37 (1.75) 7.36 (1.68) 7.39 (1.65) 7.47 (1.73) 7.50 (1.75) 
Clinic 189 204 212 231 242 
CBOCs 
     Relational Climate  10.93 (1.28) 11.16 (1.13) 11.51 (1.25) 11.75 (1.08) 10.83 (1.34) 
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Parent facility 98 100 101 108 108 
Funding available (% change 2012-
2011) 2.06 (4.03) 2.01 (3.98) 2.14 (4.01) 2.55 (6.91) 2.94 (7.73) 
Beds available 362.64 (221.87) 366.88 (226.62) 350.18 (224.07) 348.49 (219.52) 346.21 (219.19) 
Teaching status (resident/beds) 0.03 (0.08) 0.025 (0.072) 0.022 (0.06) 0.014 (0.04) 0.013 (0.04) 
Quit rate†  6.80 (1.02) 5.67 (1.22) 6.36 (1.28) 4.78 (1.44) 6.49 (1.72) 
Full time equivalent employees 2388.85 (1310.28) 2571.42 (1388.54) 2537.11 (1363.95) 2597.02 (1364.98) 2611.66 (1356.28) 
Diabetes prevalence (state level) 8.84 (1.11) 9.18 (1.26) 9.35 (1.21) 9.56 (1.33) 9.74 (1.46) 
Notes: Mean for continuous variables (SD); percentage for categorical variables (95% CI). †(Resignations/Average onboard employees) x100 
													 	107	
Table A6: Evolution of relational climate across time 
 2008 2009 2010 2011 2012 
Stations 189 204 212 231 242 
Respondents 3531 3571 4335 4426 4470 
Mean (SD) 10.93 (1.28) 11.16 (1.13) 11.51 (1.25) 11.75 (1.08) 10.83 (1.34) 
95% CI 10.72-11.14 10.95-11.37 11.30-11.72 11.54-11.96 10.62-11.04 
ICC(1) 0.095 0.111 0.138 0.093 0.126 	
 
Table A7: Observed versus predicted likelihood of guideline compliance by decile 
 
Group Total Compliant Non-compliant 
Observed Expected Observed Expected 
1 92366 24671 24481.81 67695 67884.19 
2 92367 37464 37067.71 54903 55299.29 
3 92371 43548 43588.26 48823 48782.74 
4 92364 48432 48610.18 43932 43753.82 
5 92365 52339 52844.19 40026 39520.81 
6 92367 56701 56748.17 35666 35618.83 
7 92366 60518 60696.74 31848 31669.26 
8 92367 65052 64759.13 27315 27607.87 
9 92372 69297 69356.20 23075 23015.80 
10 92348 75923 75792.47 16425 16555.53 	
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Figure A2: Distribution of the intermediate outcome indicators: LDL-C, diastolic and 
systolic blood pressure and HbA1c. 
A) LDL-C -Cholesterol 
	
 
B) Blood Pressure, systolic and diastolic 	
	
Mean 91.30 
Median 86 
Mode 76 
Skewness 1.05 
Kurtosis 3.54 	
Mean	 133.38	
Median	 132	
Mode	 130	
Skewness	 0.50	
Kurtosis	 1.03		
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C) HbA1c 
		
Mean	 74.85	
Median	 75	
Mode	 70	
Skewness	 0.22	
Kurtosis	 0.77		
Mean	 7.42	
Median	 6.9	
Mode	 6.5	
Skewness	 1.77	
Kurtosis	 5.79		
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Table A8: OLS models predicting blood pressure  
 
Systolic Blood 
Pressure 
Diastolic Blood 
Pressure 
Variable Parameter estimate (Standard Error) 
Age (ref=Above 81 years old)     
<52 -1.28 (0.09)*** 12.61 (0.06)*** 
52-57 -0.08 (0.09) 11.13 (0.06)*** 
57-71 0.39 (0.07)*** 7.16 (0.04)*** 
71-76 0.06 (0.09) 2.87 (0.06)*** 
76-81 0.06 (0.09) 1.51 (0.05)*** 
Gender (ref=male) -0.53 (0.12)*** -2.64 (0.07)*** 
Marital status (ref=Married)  
 Single 0.16 (0.08)* 0.94 (0.05)*** 
Priority status (ref=Group 1)  
 Group 2 0.25 (0.09)** 0.78 (0.05)*** 
Group 3 0.38 (0.08)*** 0.84 (0.04)*** 
Group 4 0.63 (0.11)*** -0.18 (0.06)** 
Group 5 0.63 (0.05)*** 0.39 (0.03)*** 
Group 6 0.73 (0.19)*** 1.23 (0.11)*** 
Group 7 0.42 (0.07)*** 0.49 (0.04)*** 
Elixhauser Index (ref=+4)   
 0 or 1 -3.44 (0.1)*** 1.83 (0.06)*** 
2-4 (both included) -0.23 (0.08)** 1.79 (0.05)*** 
Registry Categories (ref=0)  
 1 -1.96 (0.06)*** -1.75 (0.04)*** 
2 -2.56 (0.13)*** -2.30 (0.08)*** 
3 -1.94 (0.34)*** -2.67 (0.20)*** 
4 -2.08 (1.08) -2.68 (0.65)*** 
5 3.98 (5.23) -4.56 (3.14) 
Mental Health Diagnosis 
(ref=No) -1.47 (0.04)*** 0.29 (0.03)*** 
Insulin (ref=No) -0.43 (0.04)*** 0.32 (0.03)*** 
Relational Climate -0.004 (0.023) 0.03 (0.01) 
Diabetes prevalence 0.23 (0.07)*** -0.004 (0.92) 
Test Global Null Hypothesis 
(F-Test) <0.001 <0.001 
Hosmer-Lemeshow Test (F-
value, p-value)  
8.03                       
(0.53) 
197.46               
(<0.001) 
 Note: N=923,653. This model also adjusts for teaching status, resignation rates, number of beds and full 
time equivalent employees, which were non-significant. Also, it includes year and clinic fixed effects 
(dummies).  * p-value<0.05, ** p-value<0.01, ***p-value<0.001 
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Table A9: OLS model predicting logged cholesterol 
Variable 
Parameter estimate 
(Standard Error) 
Age (ref=Above 81 years old)   
<52 0.239 (0.002)*** 
52-57 0.171 (0.002)*** 
57-71 0.092 (0.001)*** 
71-76 0.023 (0.002)*** 
76-81 0.239 (0.002)*** 
Gender (ref=male) 0.094 (0.002)*** 
Marital status (ref=Married)   
Single 0.021 (0.002)*** 
Priority status (ref=Group 1)  
Group 2 0.028 (0.002)*** 
Group 3 0.031 (0.002)*** 
Group 4 -0.003 (0.002) 
Group 5 0.017 (0.001)*** 
Group 6 0.061 (0.004)*** 
Group 7 0.03 (0.001)*** 
Elixhauser Index (ref=+4)   
0 or 1 0.146 (0.002)*** 
2-4 (both included) 0.069 (0.002)*** 
Registry Categories (ref=0)  
1 -0.08 (0.0013)*** 
2 -0.107 (0.0028)*** 
3 -0.145 (0.007)*** 
4 -0.144 (0.022)*** 
5 -0.191 (0.10) 
Mental Health Diagnosis (ref=No) 0.013 (0.0009)*** 
Insulin (ref=No) -0.018 (0.0009)*** 
Relational Climate 0.0001 (0.0004) 
Diabetes prevalence 0.003 (0.0014)* 
 	 	Note: N=792,658. It also adjusts for teaching status, resignation rates, number of beds and full time equivalent employees, which were non-significant. Also, it 
includes year and clinic fixed effects. * p-value<0.05, ** p-value<0.01, ***p-
value<0.001 	
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Table A10: OLS model predicting logged HbA1c  
Variable 
Parameter estimate 
(Standard Error) 
Age (ref=Above 81 years old)   
<52 0.123 (0.001)*** 
52-57 0.096 (0.001)*** 
57-71 0.052 (0.0008)*** 
71-76 0.019 (0.001)*** 
76-81 0.007 (0.001)*** 
Gender (ref=male) Female -0.03 (0.0012)*** 
Marital status (ref=Married) Single 0.008 (0.0008)*** 
Priority status (ref=Group 1)  
Group 2 -0.007 (0.0009)*** 
Group 3 -0.0001 (0.0002) 
Group 4 0.012 (0.0011)*** 
Group 5 0.014 (0.0006)*** 
Group 6 -0.011 (0.002)*** 
Group 7 0.005 (0.0007)*** 
Elixhauser Index (ref=+4)   
0 or 1 -0.006 (0.001)*** 
2-4 (both included) 0.005 (0.0008)*** 
Registry Categories (ref=0)  
1 -0.009 (0.0007)*** 
2 -0.024 (0.0014)*** 
3 -0.038 (0.004)*** 
4 -0.05 (0.011)*** 
5 -0.04 (0.054) 
Teaching Status (ref=non-teaching) 0.007 (0.004)* 
Mental Health Diagnosis (ref=No) -0.017 (0.0005)*** 
Insulin (ref=No) 0.042 (0.0005)*** 
Relational Climate 0.00013 (0.0002) 
Diabetes prevalence -0.002 (0.0007)** 
	
 
Note: N=840,000. This model also adjusts for resignation rates, number 
of beds and full time equivalent employees, which were non-significant. 
Also, it includes year and clinic fixed effects (dummies). * p-value<0.05, 
** p-value<0.01, ***p-value<0.001		
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APPENDIX B 
Figure B1: Distribution and variance of the residuals from the outpatient, inpatient and 
total cost models 
i. Outpatient Costs 
 
 
Kolmogorov-Smirnov statistic (D) =0.11, Pr >D = <0.01 
 
ii. Inpatient Costs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kolmogorov-Smirnov statistic (D) =0.14, Pr >D = <0.01 
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iii. Total Costs 
 
 
 
 
 
 
 
 
 
 			
 
 
 	
Figure B2: Inpatient and outpatient deflated median costs 2008-2012 	
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Kolmogorov-Smirnov statistic (D) =0.13, Pr >D = <0.01 
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Table B1: Modified Park Test 
 
Outpatient Costs Inpatient Costs Total Costs 
 Parameter estimate (p-value) 
Lnpred† 1.97               (<0.001) 
2.01                    
(<0.001) 
1.95                    
(<0.001) 
 F-value (p-value) 
b=0‡ 677,373             (<0.001) 
194,121                 
(<0.001) 
1,295,752               
(<0.001) 
b=1 165,270              (<0.001) 
48,717.8                 
(<0.001) 
311,608             
(<0.001) 
b=2 99.16              (<0.001) 
0.72                          
(0.39) 
478.42                
(<0.001) 
b=3 181,860           (<0.001) 
47,969                   
(<0.001) 
362,362              
(<0.001) 
Note: † Lnpred includes the log of the predicted values. A statistically significant parameter 
estimate close to 2 supports the Gamma distribution. ‡ T-tests assessing the specific value of the 
parameter estimate for Lnpred. 	 	
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Figure B3: Distribution of the ratio of costs to predicted costs  
i. Outpatient costs 
 
 
G  
 
 
 
 
 
ii.    Inpatient Costs 
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Table B2: Results of the Pregibon Link Test -Log Link 
 
Parameter 
Estimate 
Standard 
Error 
Wald 95% 
Confidence 
Limits 
Wald Chi-
Square Pr > ChiSq 
Outpatient Costs 
Intercept -7.04 0.06 -7.15 -6.93 16258.4 <.0001 
xbetahat 2.62 0.01 2.6 2.65 42852.3 <.0001 
xbetahatsq -0.09 0.0007 -0.09 -0.09 16428.4 <.0001 
Inpatient Costs 
Intercept 13.46 0.19 13.09 13.82 5212.96 <.0001 
xbetahat -1.71 0.04 -1.78 -1.63 2092.49 <.0001 
xbetahatsq 0.14 0.0019 0.13 0.14 5284.21 <.0001 
Total Costs 
Intercept -0.34 0.03 -0.39 -0.28 123.59 <.0001 
xbetahat 1.07 0.01 1.06 1.09 26398.8 <.0001 
xbetahatsq -0.004 0.004 -0.005 -0.003 126.35 <.0001 
 	
iii.   Total Costs 
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Table B3: Inpatient cost model parameter estimates with 2008-2011 data 
Control MR (95% CI)† 
Age (ref=65-74 years) 		
<55 years -0.092 (-0.103,-0.079)*** 
55-64 years -0.066 (-0.075,-0.058) *** 
>75 years -0.046 (-0.055,-0.037) *** 
Gender (ref=male) -0.101 (-0.119,-0.082)*** 
Marital Status (ref=not 
married) 		
Married -0.033 (-0.039,-0.026)*** 
Enrollment Priority                     
(ref=groups 4-6) 		
Groups 1-3 -0.081 (-0.087,-0.073)*** 
Groups 7 0.078 (0.066,0.091)*** 
Log of Nosos Risk Score 
1.021                               
(1.017,1.025)*** 
Chronically Mentally Ill 
(ref=no) 
0.201                        
(0.181, 0.221)*** 
Insulin (ref=no) 
0.036                          
(0.029,0.043)*** 
Quality all-or-nothing  
(ref=no) 
-0.122                                     
(-0.129,-0.115)*** 
Relational Climate 
0.001                                      
(-0.003,0.005) 
Teaching status (ref=non-
teaching) 
0.177                         
(0.126,0.228)*** 
Notes: N=258,292. GLM model with the Gamma distribution and the Log-Link. †Log of Mean Ratios (95% 
confidence intervals). To obtain mean ratios, the coefficients need to be exponentiated. ‡ Maximum 
Likelihood estimates. To obtain odds ratios, the coefficients need to be exponentiated.                                                                         
The model also adjusts for rural/urban (non-significant) and the wage index. *** p-value<0.001, ** p-
value<0.01, * p-value<0.05.		  
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Table B4: Cost models with the number of tests as the quality indicator 
 Outpatient Costs Inpatient Costs Total Costs Number of tests 
(ref=0) 
1 0.114               (0.089,0.139)*** 
-0.128                                    
(-0.505,-0.248) 
0.149                         
(0.124,0.175)*** 
2 0.375                (0.351,0.399)*** 
-0.202                                    
(-0.578,-0.173) 
0.292                   
(0.267,0.316)*** 
3 0.576                 (0.552,0.601)*** 
-0.226                                  
(-0.601,-0.149) 
0.449                    
(0.425,0.473)*** 
4 0.748                                (0.725, 0.772)*** 
-0.281                            
(-0.656,-0.094) 
0.538                  
(0.515,0.562)*** 
5 0.948                               (0.925, 0.972)*** 
-0.384                                 
(-0.759,-0.009)* 
0.635                                 
(0.612, 0.658)*** 
Note: Results obtained from the GLM Gamma log link model adjusting for age, gender, marital 
status, enrollment priority, registry categories, Nosos risk scores, insulin medication, relational 
climate, teaching status, urban/rural and the wage index. The parameter estimates for these 
variables were comparable to the ones presented in Tables 3.2-3.4. 			
Figure B4: Hosmer-Lemeshow test results 
i. Outpatient Costs 
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ii. Inpatient Costs 
 
-188 -67 109 
300 590 
754 479 
-164 
-913 
-3918 
-5000 
-4000 
-3000 
-2000 
-1000 
0 
1000 
1 2 3 4 5 6 7 8 9 10 
M
ea
n 
re
si
du
al
 
Outpatient Cost Deciles 
GLM Model: Gamma Distribution and Log link 
920 117 -701 -941 -1473 -2070 -2837 -3072 
1012 
22022 
-5000 
0 
5000 
10000 
15000 
20000 
25000 
1 2 3 4 5 6 7 8 9 10 
M
ea
n 
R
es
id
ua
l 
Inpatient Cost Deciles 
OLS Model: Logged Cost and Duan's adjustor 
													 	121	
 
 
 
 
iii. Total Costs 
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Note: The Duan’s smearing adjustor for outpatient and total cost was 1.23 and 1.47 for inpatient costs. 
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                                                         APPENDIX C 
Table C1: Parameter estimates of the selection model predicting guideline compliance. 
Outpatient cost treatment-effects model  
Variablea OR (95% CI) 
Age (ref=<65) 
65-74 0.983 (0.974,0.993)** 
>=75 0.661 (0.652,0.671)*** 
Gender (ref=female) 
Male 1.013(0.989,1.038) 
Marital status  (ref=single) 
Married 1.028 (1.019,1.041)*** 
Enrollment priority                                                         
(ref=1-3) 
Groups 4-6 0.961 (0.951,0.971)*** 
Group 7-8 0.827 (0.816,0.838)*** 
Chronically mentally ill  
(ref=no) 
Yes 1.064 (1.054,1.074)*** 
Elixhauser Index (ref=+4) 
 0 or 1 0.429 (0.419,0.431)*** 
2-4 (both included) 0.745 (0.718,0.748)*** 
Registry Categories (ref=0) 
 1 0.928 (0.916,0.942)*** 
2 0.739 (0.718,0.761)*** 
3 0.709 (0.661,0.776)*** 
4 0.674 (0.539,0.841)*** 
5 0.582 (0.193,1.752) 
Insulin (ref=no) 
 Yes 1.626 (1.611,1.641)*** 
Relational climate 1.043 (1.039,1.047)*** 
Teaching status (ref=no)   
Yes 1.161 (1.102,1.206)*** 
Quit rate 0.818 (0.811,0.825)*** 
Diabetes prevalence 1.057 (1.061,1.054)*** 	
Notes: a This model also adjusts for the number of beds, full time equivalent employees, which were non-
significant. * p-value<0.05, ** p-value<0.01, ***p-value<0.001.  		
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Table C2: Parameter estimates of the selection model predicting guideline compliance. 
Inpatient cost treatment-effects model  
Variablea OR (95% CI) 
Age (ref=<65) 
65-74 0.979 (0.963,0.996)** 
>=75 0.611 (0.597,0.625)*** 
Gender (ref=female) 
Male 1.036(0.989,1.007) 
Marital status  (ref=single) 
Married 1.035 (0.925,1.007) 
Enrollment priority                                                         
(ref=1-3) 
Groups 4-6 0.851 (0.838,0.865)*** 
Group 7-8 0.861 (0.838,0.884)*** 
Chronically mentally ill  
(ref=no) 
Yes 1.118 (1.101,1.136)*** 
Elixhauser Index 
(ref=+4) 
 0 or 1 0.344 (0.334,0.354)*** 
2-4 (both included) 0.855 (0.818,0.878)*** 
Registry Categories 
(ref=0) 
 1 0.782 (0.768,0.796)*** 
2 0.637 (0.617,0.657)*** 
3 0.594 (0.552,0.641)*** 
4 0.565(0.451,0.606)*** 
5 0.451 (0.397,1.339) 
Insulin (ref=no) 
 Yes 1.249(1.229,1.269)*** 
Relational climate 1.035 (1.028,1.042)*** 
Teaching status 
(ref=no)   
Yes 1.391 (1.302,1.508)*** 
Quit rate 0.744 (0.731,0.756)*** 
Diabetes prevalence 1.098 (1.089,1.102)*** 
 
Notes: a This model also adjusts for the number of beds, full time equivalent employees, which were non-
significant. * p-value<0.05, ** p-value<0.01, ***p-value<0.001.  			
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Table C3: Parameter estimates of the selection model predicting guideline compliance. 
Total cost treatment-effects model  	
Variablea OR (95% CI) 
Age (ref=<65) 
65-74 0.987 (0.977,0.997)** 
>=75 0.665 (0.655,0.675)*** 
Gender (ref=female) 
Male 1.206 (0.994,1.044) 
Marital status  (ref=single) 
Married 1.027 (1.017,1.036)*** 
Enrollment priority                                                         
(ref=1-3) 
Groups 4-6 0.953 (0.944,0.963)*** 
Group 7-8 0.828 (0.814,0.839)*** 
Chronically mentally ill  
(ref=no) 
Yes 1.061 (1.051,1.071)*** 
Elixhauser Index (ref=+4) 
 0 or 1 0.311 (0.303,0.316)*** 
2-4 (both included) 0.731 (0.701,0.742)*** 
Registry Categories (ref=0) 
 1 0.935 (0.922,0.948)*** 
2 0.756 (0.735,0.778)*** 
3 0.721 (0.671,0.774)*** 
4 0.674 (0.541,0.842)*** 
5 0.586 (0.195,1.763) 
Insulin (ref=no) 
 Yes 1.624 (1.611,1.639)*** 
Relational climate 1.043 (1.039,1.047)*** 
Teaching status (ref=no)   
Yes 1.141 (1.095,1.198)*** 
Quit rate 0.818 (0.811,0.825)*** 
Diabetes prevalence 1.057 (1.061,1.054)*** 	
Notes: a This model also adjusts for the number of beds, full time equivalent employees, which were non-
significant. * p-value<0.05, ** p-value<0.01, ***p-value<0.001.  	
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Table C4: Balance check for the outpatient cost treatment-effects model 
 
Standardized 
differences† Variance ratio‡ 
Variable Raw Weighted Raw Weighted 
Age (ref=<65) 
   
 
65-80 0.011 0.0007 1.006 1.001 
>=80 -0.141 0.0002 0.697 1.001 
Gender  
   
 
Male -0.005 -0.0003 1.026 1.001 
Marital status   
  1.004 
 
Married -0.031 0.0005 0.999 
Enrollment priority 
(ref=1-3)              
   
 
Groups 4-6 -0.0006 -0.001 0.999 0.999 
Group 7-8 -0.088 0.0009 0.846 1.002 
Insulin (ref=no) 
   
 
Yes 0.252 0.0001 0.882 0.999 
Relational climate 0.061 -0.0008 0.968 0.992 
Elixhouser Index 
   
 
2 to 4 0.185 0.003 0.753 0.995 
More than 4 0.096 -0.002 1.388 0.992 
Mental (ref=no) 
    Yes 0.096 -0.0004 1.047 0.999 
Quit rate* -0.09 0.0005 0.942 0.987 
Full-time 
equivalent 
employees 
0.00005 0.0006 0.931 0.947 
Number of beds 0.003 0.002 0.962 0.963 
Note: † standardized differences are computed as: !!"#$!#%!!!"!#$%&#%'!!"#$!#%! !!!"!#$%&#%'!!  where 𝑥!"#$!#%  and 𝑥!"!#$%&#%'  denote 
the sample mean of the covariate in treated and non-treated subjects, respectively. 𝑠!"#$!#%!  and 𝑠!"!#$%&#%'!  
denote the sample variance of the covariate in treated and non-treated subjects. ‡ variance ratios are the 
mean ratio of the variable in treated subjects to the variance in untreated subjects. *(Resignations/Average 
onboard employees) x100 
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Table C5: Balance check for the inpatient cost treatment-effects model 
 
Standardized† 
differences Variance ratio‡ 
Variable Raw Weighted Raw Weighted 
Age (ref=<65) 
   
 
65-80 0.046 0.002 1.028 1.001 
>=80 -0.179 -0.001 0.676 0.997 
Gender  
   
 
Male -0.007 -0.0009 1.037 1.005 
Enrollment priority 
(ref=1-3)              
   
 
Groups 4-6 -0.081 -0.0003 0.967 0.999 
Group 7-8 -0.017 -0.0005 0.953 0.999 
Insulin (ref=no) 
   
 
Yes 0.117 0.0001 0.927 0.999 
Relational climate 0.066 -0.003 1.021 1.032 
Elixhouser Index 
   
 
2 to 4 0.112 0.003 0.843 0.995 
More than 4 0.093 -0.0009 1.248 0.998 
Mental (ref=no) 
    Yes -0.021 0.0016 1.001 0.999 
Quit rate* -0.117 0.0009 0.915 0.977 
Full-time 
equivalent 
employees 
-0.014 0.002 0.911 0.939 
Number of beds -0.128 0.004 0.955 0.957 
Teaching (ref=no) -0.062 -0.0003 0.571 0.997 
Note: † standardized differences are computed as: !!"#$!#%!!!"!#$%&#%'!!"#$!#%! !!!"!#$%&#%'!!  where 𝑥!"#$!#%  and 𝑥!"!#$%&#%'  denote 
the sample mean of the covariate in treated and non-treated subjects, respectively. 𝑠!"#$!#%!  and 𝑠!"!#$%&#%'!  
denote the sample variance of the covariate in treated and non-treated subjects. ‡ variance ratios are the 
mean ratio of the variable in treated subjects to the variance in untreated subjects. *(Resignations/Average 
onboard employees) x100 
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Table C6: Balance check for the total cost treatment-effects model 
 
Standardized† differences Variance ratio‡ 
Variable Raw Weighted Raw Weighted 
Age (ref=<65) 
   
 
65-80 0.011 0.0007 1.006 1.001 
>=80 -0.141 0.0002 0.697 1.001 
Gender      
Male -0.005 -0.0003 1.026 1.001 
Marital status     
1.004 
 
Married -0.031 0.0005 0.999 
Enrollment priority 
(ref=1-3)                  
Groups 4-6 -0.0006 -0.001 0.999 0.999 
Group 7-8 -0.088 0.0009 0.846 1.002 
Insulin (ref=no)     
Yes 0.252 0.0001 0.882 0.999 
 Nosos      
Relational climate 0.061 -0.0008 0.968 0.992 
Elixhouser Index     
2 to 4 0.185 0.003 0.753 0.995 
More than 4 0.096 -0.002 1.388 0.992 
Mental (ref=no)     
Yes 0.096 -0.0004 1.047 0.999 
Quit rate* -0.09 0.0005 0.942 0.987 
Full-time 
equivalent 
employees 
0.00005 0.0006 0.931 0.947 
Number of beds 0.003 0.002 0.962 0.963 
Note: † standardized differences are computed as: !!"#$!#%!!!"!#$%&#%'!!"#$!#%! !!!"!#$%&#%'!!  where 𝑥!"#$!#%  and 𝑥!"!#$%&#%'  denote 
the sample mean of the covariate in treated and non-treated subjects, respectively. 𝑠!"#$!#%!  and 𝑠!"!#$%&#%'!  
denote the sample variance of the covariate in treated and non-treated subjects.‡ variance ratios are the 
mean ratio of the variable in treated subjects to the variance in untreated subjects. *(Resignations/Average 
onboard employees) x100 
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Figure C1: Evolution of the study variables across time by compliance status 
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Note: †(Resignations/Average onboard employees) x100 
 
Table C7: Partition of the Hosmer-Lemeshow Test 
 
Non-compliant Compliant 
Decile  Observed Expected Ratio Observed Expected Ratio 
1 25644 25480.620 1.006 69959 70122.380 0.998 
2 39020 38558.560 1.012 56604 57065.440 0.992 
3 45148 45273.270 0.997 50453 50327.730 1.002 
4 50364 50415.040 0.999 45239 45187.960 1.001 
5 54290 54766.870 0.991 41314 40837.130 1.012 
6 58577 58827.150 0.996 37024 36773.850 1.007 
7 62722 62844.170 0.998 32886 32763.830 1.004 
8 67297 67000.360 1.004 28305 28601.640 0.990 
9 71696 71791.710 0.999 23906 23810.290 1.004 
10 78516 78316.080 1.003 17059 17258.920 0.988 
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Figure C2: Bootstrapping of the Hosmer-Lemeshow test p-value  
 
 
 
Note: Results based on 100 random samples of 50,000 observations each 
 
 
Figure C3: Bootstrapping of the Pregibon link test p-value  
 
 
 
Note: Results based on 100 random samples of 50,000 observations each 
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Table C8: Sensitivity analysis 1: Parameter estimates if insulin is dropped from the 
treatment equation  
a) Outpatient Costs 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 -0.015 (-0.021, -0.011)*** 0.006 (0.002, 0.009)*** 
>=75 -0.114 (-0.122, -0.107)*** -0.111 (-0.118, -0.104)*** 
Gender (ref=female) 
 Male -0.138 (-0.151, -0.126)*** -0.118 (-0.128, -0.109)*** 
Marital status  (ref=single)   
Married -0.138 (-0.151, -0.126)*** 0.018 (0.014, 0.022)*** 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 -0.602 (-0.066, -0.055)*** -0.059 (-0.063, -0.055)*** 
Group 7-8 -0.174 (-0.181, -0.167)*** -0.157 (-0.162, -0.151)*** 
Chronically mentally ill  
(ref=no)   
Yes 0.188 (0.165, 0.211)*** 0.106 (0.089, 0.124)*** 
Log Nosos  0.791 (0.789, 0.793)*** 0.743 (0.742, 0.745)*** 
Relational climate -0.003 (-0.004, -0.001)** -0.006 (-0.007, -0.004)*** 
Teaching status 
(ref=no) 
  Yes 0.123 (0.103, 0.144)*** 0.06 (0.042, 0.079)*** 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean Ratio (MR) 
and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
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b) Inpatient Costs 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 0.052 (0.041, 0.642)*** 0.068 (0.059, 0.078)*** 
>=75 -0.018 (-0.034, -0.003)* -0.021 (-0.035, -0.006)** 
Gender (ref=female) 
 Male 0.085 (0.055, 0.115)*** 0.117 (0.093, 0.141)*** 
Marital status  (ref=single)   
Married -0.047 (-0.058, -0.036)*** -0.038 (-0.046, -0.029)*** 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 0.067 (0.055, 0.078)*** 0.087 (0.078, 0.096)*** 
Group 7-8 0.135 (0.116, 0.154)*** 0.165(0.151, 0.79)*** 
Chronically mentally ill  
(ref=no)   
Yes 0.312 (0.283, 0.341)*** 0.257 (0.232, 0.283)*** 
  Log Nosos  1.021 (1.014, 1.028)*** 0.988 (0.982, 0.994)*** 
Relational climate -0.014 (-0.018, -0.009)*** -0.017 (-0.021, -0.014)*** 
Teaching status 
(ref=no) 
  Yes 0.002 (-0.038, 0.427) -0.129 (-0.173, -0.086)*** 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean Ratio (MR) 
and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
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c) Total costs 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 0.029 (0.024,0.035)*** 0.051 (0.046,0.545)*** 
>=75 -0.033 (-0.041,-0.025)*** -0.037 (-0.045,-0.031)*** 
Gender (ref=female) 
 Male -0.034 (-0.047,-0.021)*** -0.022 (-0.032,-0.012)*** 
Marital status  (ref=single)   
Married -0.008 (-0.013,-0.003)** 0.002 (-0.002,0.006) 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 0.013 (0.008,0.019)*** 0.019 (0.015,0.023)*** 
Group 7-8 -0.059 (-0.066,-0.052)*** -0.028 (-0.341,-0.022)*** 
Chronically mentally ill  
(ref=no)   
Yes 0.092 (0.718,0.112)*** 0.078 (0.061,0.095)*** 
Log Nosos  
  Relational climate -0.007 (-0.009,-0.005)*** -0.011 (-0.013,-0.009)*** 
Teaching status 
(ref=no) 
  Yes 0.088 (0.067,0.109)*** -0.011 (-0.03,0.009) 
Urban/Rural 
(ref=rural) -0.047 (-0.057,-0.036)*** -0.033 (-0.042,-0.023)*** 
Notes: a The model also adjusts for the wage index. †Log Mean Ratio (MR) and 95% Confidence Interval 
(95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
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Table C9: Sensitivity analysis 2: Parameter estimates with alternative top-coding 
thresholds for inpatient costs 
 
a) Top coding at 1 million 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 0.029 (0.024,0.035)*** 0.051 (0.046,0.054)*** 
>=75 -0.033 (-0.041,-0.025)*** -0.037 (-0.045,-0.031)*** 
Gender (ref=female) 
 Male -0.034 (-0.047,-0.021)*** -0.022 (-0.032,-0.012)*** 
Marital status  (ref=single)   
Married -0.008 (-0.013,-0.003)** 0.002 (-0.002,0.006) 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 0.013 (0.008,0.019)*** 0.019 (0.015,0.024)*** 
Group 7-8 -0.059 (-0.066,-0.052)*** -0.028 (-0.034,-0.022)*** 
Chronically mentally ill  
(ref=no)   
Yes 0.092 (0.072,0.112)*** 0.078 (0.061,0.955)*** 
Insulin (ref=no)  
                                    Yes     0.084 (0.079,0.089)*** 0.053 (0.049,0.058)*** 
Log Nosos  1.143 (1.141,1.145)*** 1.058 (1.056,1.059)*** 
Relational climate -0.007 (-0.009,-0.005)*** -0.011 (-0.013,-0.009)*** 
Teaching status 
(ref=no) 
  Yes 0.088 (0.067,0.109)*** -0.011 (-0.031,0.009) 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean Ratio (MR) 
and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-value<0.05 
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b) Top coding at Top-coding at $114,955 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 0.053 (0.041,0.065)*** 0.068 (0.059,0.077)*** 
>=75 -0.019 (-0.034,-0.004)*** -0.021 (-0.035,-0.006)** 
Gender (ref=female) 
 Male 
 
0.117 (0.094,0.141)*** 
Marital status  (ref=single)   
Married 0.086 (0.056,0.117)*** -0.038 (-0.047,-0.029)*** 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 0.067 (0.055,0.078)*** 0.087 (0.078,0.096)*** 
Group 7-8 0.134 (0.115,0.152)*** 0.164 (0.149,0.178)*** 
Chronically mentally ill  
(ref=no)   
Yes 0.316 (0.287,0.345)*** 0.257 (0.231,0.283)*** 
Insulin (ref=no) 
                                    Yes     0.017 (0.006,0.028)** 0.046 (0.037,0.055)*** 
Log Nosos  1.019 (1.013,1.027)*** 0.988 (0.982,0.993)*** 
Relational climate -0.013 (-0.018,-0.009)*** -0.017 (-0.211,-0.014)*** 
Teaching status 
(ref=no) 
  Yes -0.0004 (-0.041,0.039) -0.131 (-0.174,-0.088)*** 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean 
Ratio (MR) and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-
value<0.05 
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Table C10: Sensitivity analysis 3: Relational climate parameter estimates if 2012 
inpatient cost data is dropped 
 
Quality=0 Quality=1 
Variablea Log MR† (95% CI) Log MR†(95% CI) 
Age (ref=<65)   
65-74 0.058 (0.044,0.072)*** 0.069 (0.058,0.079)*** 
>=75 -0.011 (-0.028,0.006) -0.014 (-0.031,0.001) 
Gender (ref=female) 
 Male 0.093 (0.059,0.128)*** 0.118 (0.091,0.145)*** 
Marital status  (ref=single) 
 Married -0.044 (-0.056,-0.031)*** -0.041 (-0.049,-0.031)*** 
Enrollment priority                                                         
(ref=1-3) 
 Groups 4-6 0.064 (0.051,0.077)*** 0.086 (0.075,0.958)*** 
Group 7-8 0.131 (0.109,0.152)*** 0.167 (0.151,0.183)*** 
Chronically mentally ill  
(ref=no) 
 Yes 0.317 (0.283,0.351)*** 0.234 (0.204,0.264)*** 
Insulin (ref=no) 
                                    Yes     0.023 (0.009,0.035)*** 0.048 (0.038,0.058)*** 
Log Nosos  1.018 (1.011,1.026)*** 0.991 (0.984,0.996)*** 
Relational climate -0.016 (-0.021,-0.011)*** -0.021 (-0.024,-0.016)*** 
Teaching status 
(ref=no) 
  Yes -0.002 (-0.042,0.039) -0.134 (-0.178,-0.091)*** 
Notes: a The model also adjusts for rural/urban (non-significant) and the wage index. †Log Mean 
Ratio (MR) and 95% Confidence Interval (95% CI) *** p-value<0.001, ** p-value<0.01, * p-
value<0.05 
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